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Abstract 
Superbug infection is one of the greatest public health threat with grave 
implications across all levels of society. Towards a new solution to combat 
infection by multi-drug resistant bacteria, this thesis presents an engineering 
framework and genetic tools applied to repurpose commensal bacteria into 
“micro-robots” for the treatment of superbug infection. Specifically, a prototype 
of designer probiotic was developed using the human commensal bacteria 
Escherichia coli. The engineered commensal was reprogrammed with user-
specified functions to sense superbug, produced pathogen-specific killing 
molecules and released the killing molecules via a lytic mechanism. The 
engineered commensal was effective in suppressing ~99% of planktonic 
Pseudomonas and preventing ~ 90% of biofilm formation. To enhance the 
sensing capabilities of engineered commensal, genetic interfaces comprising 
orthogonal AND & OR logic devices were developed to mediate the integration 
and interpretation of binary input signals. Finally, AND, OR and NOT logic 
gates were networked to generate a myriad of cellular logic operations 
including half adder and half subtractor. The creation of half adder logic 
represents a significant advancement of engineering human commensal to be 
biological equivalent of microprocessor chips in programmable computer with 
the ability to process input signals into diversified actions.  Importantly, this 
thesis provides exemplary case studies to the attenuation of cellular and 
genetic context dependent effects through principles elucidated herein, 
thereby advancing our capability to engineer commensal bacteria.  
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Chapter One 
1. INTRODUCTION 
1.1 Background and Motivation 
One of the biggest public health threats that the world is facing today is the 
rapid emergence of superbug infection. Superbugs are bacterial pathogens 
that gained tolerance to commonly-used antibiotics and continue to proliferate 
in the presence of inhibitory concentration of the antibiotics1. In the most 
recent and biggest study by far, the World Health Organisation (WHO) 
analysed data from 114 countries and acknowledged that the superbug crisis 
may be worse than the 1980s Aids epidemic – which had claimed over 25 
million lives worldwide and “threatens to turn the clock back on modern 
medicine”2. Two classes of superbug exist; in the first class, commensal 
bacteria including Staphylococcus aureus and Enterococci which naturally 
reside in the human body, acquire virulent and antibiotic-resistant genes 
through horizontal gene transfer and convert into infectious pathogens3. 
Opportunistic bacteria that originate from the surroundings and cause infection 
among immunocompromised patients such as those undergoing cancer 
chemotherapy, infected with HIV, infants or elderly patients, form the second 
class of superbug pathogens. Due to protracted exposure to rigorous 
environment, opportunistic bacteria are adapted with multi-drug resistant 
genes and have been suggested to be the evolutionary origins of antibiotic 
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resistance in clinical pathogens4. While antibiotics had been effective in 
controlling the spread of bacterial infection in the early 1960s, it is evident that 
the current development of antibiotics cannot cope with the speed at which 
bacterial pathogens evolved against our existing arsenal of antibiotics.  
 
Increasingly, the risk of common infection and minor injuries exacerbating into 
critical health conditions have been frequently observed across all levels in 
society, pronouncing the need for new approaches to combat infections 
caused by multi-drug resistant bacteria. Contemporary treatments against 
superbug infection include antibiotic chemotherapy and bacteriophage therapy. 
In antibiotic chemotherapy, a combinatorial treatment involving multiple 
antimicrobial agents is usually preferred over monotherapy due to the rapid 
acquisition of drug tolerance among opportunistic bacteria. This approach, 
however, promotes unspecific killing of bacteria and upsets a healthy human 
microbiome and immune system, thereby increasing one’s vulnerability to 
infection by other pathogens. Phage therapy involves strain-specific 
bacteriophages that invade and destroy the cellular integrity of pathogens5. 
The therapeutic potential of employing virus in bacterial infection, however, is 
limited, as a directed treatment cannot be re-employed after the infected host 
develops specific antibodies against the introduced virus6. Bacterial pathogens 
also commonly acquire immunity to phage attacks by (1) altering cell surface 
receptors, (2) producing masking proteins and exopolysaccharides to reduce 
phage adsorption7, or (3) deactivating viral DNA through CRISPR spacers in 
similar fashion as RNA interferences among eukaryotic organisms 8. 
Nonetheless, phage therapy remains as one of the most promising alternatives 
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to the control of superbug infection among immunocompromised patients as 
exemplified in several recent studies by Lu and colleagues using phage 
synthetic biology9-13.  
 
Probiotics modulate inflammatory responses14 and protect humans against 
infection through a myriad of mechanisms including deactivation of toxins, 
inhibition of pathogens in gut, urinary and respiratory tracts and activation of 
innate immune system15-17. In other studies, probiotics have also been 
demonstrated to positively regulate metabolic diseases18, food allergies19, 
neurodevelopmental disorders20 and cancer treatments21. Drawing inspiration 
from nature, designer probiotics may prove to be a potent weapon in the fight 
against superbug infection if augmented with the right set of genetic tools and 
functions. The advantages of using probiotics as prophylactic and therapeutic 
measures for infection control are multi-fold. Firstly, probiotics are known to 
survive transition across the gastrointestinal tract and can serve as excellent 
delivery vehicle. Secondly, the designer probiotics presented in this thesis only 
targeted Pseudomonas pathogen while leaving the rest of the gut microbiota 
intact. This is crucial to maintain a healthy immune function and prevent the 
occurrence of secondary infection by other pathogens. Finally, the designer 
probiotics can be genetically tailored to incorporate kill-switches that prevent 
their survival beyond target host or to ameliorate additional human health 
complications such as insulin resistance and obesity. In all, designer probiotics 
are practical means to precision medicine. 
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Synthetic biology aims to engineer genetically modified biological systems that 
perform novel functions that do not exist in nature, with reusable, standard 
interchangeable biological parts. The use of these standard biological parts 
enables the exploitation of common engineering principles such as 
standardization, decoupling, and abstraction for synthetic biology22. With this 
engineering framework in place, synthetic biology has the potential to make 
the construction of novel biological systems a predictable, reliable, systematic 
process. While the development of most synthetic biological systems still 
remains largely ad hoc, recent efforts to implement an engineering framework 
in synthetic biology have provided long awaited evidence that engineering 
principles can facilitate the construction of novel biological systems. Thus far, 
synthetic biology principles have been successfully applied to develop novel 
biological systems of various applications, such as drugs and biofuels 
production23-27, microbiota restructuring28, and even cancer therapy29. Given 
the stalled development of new antibiotics and the increasing emergence of 
multi-drug-resistant pathogens, using synthetic biology to design new 
treatment regimens for infectious disease could address an urgent need.  
 
1.2 Objectives and Milestones 
The overall aim of this thesis was to develop a framework for the rational 
engineering of commensal bacteria with human-specified functions. 
Specifically, commensal bacteria were genetically reprogrammed into “micro-
robots” and equipped with novel, regulated functions for the prevention and 
treatment of superbug infection. Studies described in this thesis were 
independently performed in Nanyang Technological University (Singapore) 
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and Imperial College London (United Kingdoms). Specific objectives, tasks 
and milestones are as follows:  
I. Genetic engineering of commensal microbe to sense and eradicate a 
common superbug pathogen, Pseudomonas aeruginosa. This proof-of-
concept study would serve as an exemplary reference to how the synthetic 
biology engineering framework could be harnessed to develop designer 
probiotic against specific superbug infection. 
II. Development of genetic interfaces that could integrate multiple input 
signals to produce specific outputs for enhanced biosensing capabilities. 
This proof-of-concept study entailed the execution of digital operation (AND 
& OR binary logic) in whole cell biosensor to improve the specificity and 
sensitivity of detecting dual input signals. The design framework 
established herein would significantly simplify the engineering of digital 
operation in living cells and can be applied in other related projects. 
III. Programming autonomous decision-making in commensal microbe with 
biological half adder. This task built on the networking of logic devices 
developed in Task II to exhibit advanced half adder logics. Half adders are 
basic units in microprocessor chips with programmable decision-making 
functions. The design principles established in this study, in particular 
causes, effects and solutions to genetic context dependency, would be of 
significance usefulness for future design of complex genetic devices and 
circuits. 
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1.3 Thesis Outline and Organisation 
Superbug infection is one of the greatest public health threat with grave 
implications across all levels of society. Towards a new solution to combat 
infection by multi-drug resistant bacteria, this thesis presents an engineering 
framework and genetic tools applied to repurpose commensal bacteria into 
“micro-robots” for the treatment of superbug infection. In Chapter 1, the 
thesis’s background information, motivation, and defining objectives are 
described and discussed.  
 
Chapter 2 presents the literature review of the biological properties of the 
model superbug targeted in this thesis, P. aeruginosa. A comprehensive 
review of synthetic biology concept in medical biotechnology is discussed. The 
chapter also presents an overview of synthetic genetic circuits and logic 
devices that have been developed to date.  
 
Chapter 3 presents the detailed methods that were performed in the studies 
outlined in this thesis. This includes the protocols that were performed to 
design, assemble, characterise and evaluate the effectiveness of the 
engineered microbe in sensing and eradicating the model superbug, and those 
which were used to develop and characterise genetic logic gates that enabled 
engineered E. coli to function as biological microprocessor.  
 
Chapter 4 presents the design principles that were applied to engineer 
commensal E. coli into a therapeutic microbe against Pseudomonas infection 
and the corresponding results (Task I). Specifically, the commensal bacteria 
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were reprogrammed with user-specified functions to sense superbug, 
produced pathogen-specific killing molecules and released the killing 
molecules via a lytic mechanism. 
 
To enhance the sensing capabilities of engineered commensal, genetic 
interfaces comprising orthogonal AND & OR logic devices were developed to 
mediate the integration and interpretation of binary input signals. Chapter 5 
presents a novel forward engineering approach to enable AND & OR digital 
operations in synthetic biological systems (Task II). As a proof of concept 
study, the genetic interfaces developed in this chapter were systematically 
characterised using prebiotic sugar inducers, arabinose and rhamnose.  
 
Chapter 6 presents the engineering principles and challenges faced in the 
integration of disparate bio-logical devices to repurpose E. coli with half adder 
computational function (Task III). The half adder is an advanced digital logic 
operation that demonstrates both AND & XOR outputs from binary inputs. A 
half subtractor was also developed to illustrate the flexibility of the synthetic 
biology approach adopted in this study.  
 
Chapter 7 presents a summary of novel contributions of this thesis to the 
scientific community. Additional viewpoints on possible future plans to advance 
the development of designer probiotics in terms of introducing new genetic 
functions  (engineered cell motility and biofilm dispersal), and bringing the 
engineered commensal bacteria into a next phase of pre-clinical animal testing 
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are discussed. Appendix and references acknowledged in this thesis are 
presented in Chapter 8 and 9 respectively. 
 
1.4 List of Publications  
Saeidi Nazanin, Choon Kit Wong* et al. Engineering microbes to sense and 
eradicate Pseudomonas aeruginosa, a human pathogen. Mol Syst Biol 7 
(2011).              *co-first author 
 
Choon Kit Wong et al. in Engineering and Analyzing Multicellular Systems, 
Vol. 1151. (eds. L. Sun & W. Shou) Springer New York, 117- 133 (2014). 
 
Choon Kit Wong et al. Isolated nucleotide molecule and method of sensing 
and killing pathogenic microorganism. US Patent 9,044020 B2. (2015) 
 
Adison Wong et al. Layering genetic circuits to build a single cell, bacterial 
half adder. (2014). BMC Biol 13 (2015) 
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Chapter Two 
2. LITERATURE REVIEW 
In this chapter, the pathogenic properties of Pseudomonas aeruginosa (P. 
aeruginosa) are reviewed with special emphasis on their multi-drug resistant 
and quorum sensing properties driving virulence behaviour. Next, an overview 
of pyocins – antimicrobial peptides derived from environmental derivatives of P. 
aeruginosa and specific against clinical isolates of P. aeruginosa – are 
introduced. A comprehensive literature review on the field of synthetic biology 
is then presented. Specifically, the core engineering principles and 
biotechnological applications associated with synthetic biology, and the 
challenges of engineering synthetic gene circuits are discussed. Finally, the 
concept of analog and digital genetic circuits, and how digital circuits can be 
programmed to display digital operations are explained.  
 
2.1 Pseudomonas aeruginosa as an Opportunistic Pathogen 
P. aeruginosa is an opportunistic, gram-negative bacterium, commonly 
associated with causing chronic, nosocomial infections among cystic fibrosis 
and immune-compromised patients. Among hospital acquired infection, 
marrow transplant and neutrophenic patients with compromised immune 
systems are gravely vulnerable to P. aeruginosa associated outbreaks of 
pneumonia and septicaemia, accounting for an estimated mortality rate of 
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30%30. Cystic fibrosis (CF) patients who lack the ability to regulate mucus due 
to mutation in the gene coding for protein cystic fibrosis transmembrane 
conductance regulator are also lethally susceptible to P. aeruginosa infection 
31. Bacteria colonization along the respiratory tracts developed biofilms, 
leading to breathing difficulties and high fatalities among CF patients.  
Contemporary treatments against P. aeruginosa infection include 
chemotherapy using a combination of potent antibiotics and phage therapy 
with strain-specific bacteriophage that destroy cellular integrity of the 
pathogen5, 32. Such methods are however ineffective in due course as (i) drug 
exposure incites mutation in the antibiotic resistance genes overtime, allowing 
P. aeruginosa to develop resistance against synthetic antibiotics and prevent 
vital metabolic activities from being affected by its introduction, and (ii) phage 
directed treatment cannot be employed a second time after infected host 
developed immunity against the introduced virus6. With the pace of 
spontaneous mutation far exceeding the development of antibiotics, acquired 
multidrug resistance in P. aeruginosa has presented an unparalleled challenge 
to medical treatments33, 34. 
 
Clinical treatments to infection initiated by P. aeruginosa remain a central 
issue among medical researchers due to the pathogen’s enhanced resistance 
to numerous antibiotics. Several mechanisms have been proposed to 
elucidate its innate defences against antibiotics, for example its low-
permeability cellular envelope against extracellular antibiotics, the presence of 
multidrug efflux systems for drug rejection, the expression of an antibiotic 
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deactivation protein encoded by ampC gene and horizontal gene transfer of 
plasmid, transposons or phages harbouring antibiotic resistance cassettes35, 36.   
 
Table 2-1. Antibiotic efflux pumps. The table is adapted from 35, 36 with 
permission. 
Efflux pump Substrate 
MexAB-OprM 
β-lactams, fluoroquinones, chloramphenicol, macrolides, 
novobiocins, sulphonamides, tetracycline, trimethoprim 
MexCD-OprJ 
Anti-PA PCN, chloramphenicol, CPM, fluoroquinones, 
macrolides, MERO, novobiocins, trimethoprim 
MexEF-OprN 
carbapenems, chloramphenicol, fluoroquinones, 
trimethoprim 
MexJK erythromycin, tetracycline 
MexGHL-OpmD fluoroquinones 
MexVW 
chloramphenicol, erythromycin, fluoroquinones, 
tetracycline, 
MexPQ-OpmE chloramphenicol, fluoroquinones, macrolides, tetracycline 
MexMN chloramphenicol 
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Figure 2-1: Multidrug efflux pumps of P. aeruginosa. (A) Chromosomal genes encoding for 
multiple efflux system and beta-lactamase. (B) Schematic of efflux pumps removing antibiotics 
from the inner cytoplasm and periplasm out of the cell. CM: cytoplasmic membrane, PG: 
peptidoglycan, OM: outermembrane, LPS: lipopolysaccharides, ALG: alginate. The figure is 
reproduced from 35 with permission.    
 
Figure 2-1 shows the genomic mapping and graphical illustration of multiple 
efflux system in PAO135. Each multidrug efflux pump is composed of three 
modules; an antiporter embedded across the cytoplasmic membrane, a protein 
linker and an outer-membrane porin for expulsion of molecules with toxic 
effects on Pseudomonas viability. Other than polymyxins, all other classes of 
antibiotics are susceptible to the effects of multidrug efflux pumps. Although 
the genes are encoded in all isolates of P. aeruginosa, their expressions are 
tightly controlled by regulatory repressors in an antibiotic-free environment to 
preserve energy for other pivotal cellular activities. Nonetheless, drug 
exposure may incite mutation in the antibiotic regulatory genes, leading to 
enhanced expression of drug efflux systems and allowing P. aeruginosa to 
develop resistance against novel antibiotics.  
ampC 
ampR 
mexCD-oprJ 
mexAB-oprM 
mexXY 
mexEF-oprN 
P. aeruginosa 
6,264,403 bp 
A B 
Antibiotic removed by 
efflux pump before acting 
ALG 
LPS 
OM 
PG 
CM 
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The bacterial community in a biofilm is protected by an excreted matrix of 
extracellular polymeric substance (EPS) composed of polysaccharides and 
proteins. The development of a biofilm impedes drug delivery to target sites of 
infection and greatly reduces the efficacy of antibiotics. Three possible 
mechanisms of antibiotic resistance in biofilms are shown in the Figure 2-237. 
The first defence mechanism (yellow) is slow or incomplete penetration of the 
antibiotic into the biofilm after being deactivated in the surface layers. The 
second mechanism38 proposes that a subpopulation of P. aeruginosa in biofilm 
differentiates into a highly protected phenotypic state which is invulnerable to 
antibiotics. The third protective system39 which occurs deep within the biofilm 
illustrates a nutrient depleted zone rich in waste concentrations where 
antibiotic effects are nullified. These mechanisms allow P. aeruginosa to 
persist on infected surfaces and cause recurrent infections. P. aeruginosa is 
highly adaptable to differing host environment. In addition to its potential to 
exploit diverse carbon sources ranging from glucose to diesel for growth and 
metabolism, it is also able to survive in anaerobic conditions by utilizing nitrate 
or arginine as a respiratory electron acceptor.  These strategies are critical to 
its survival in challenging conditions, such as in cystic fibrosis infections where 
oxygen diffusion is restricted.  
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Figure 2-2: Antibiotic resistance of bacteria in biofilms. (1) The biofilm matrix is an obstacle to 
diffusion and causes the inactivation of antibiotics. (2) A sub-population of P. aeruginosa may 
differentiate into antibiotic-resilient phenotype and co-exist with antibiotic-sensitive cells. The 
figure is reproduced from 37 with permission. 
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2.2 Quorum sensing in P. aeruginosa  
Quorum sensing (population sensing) is an organic chemical signalling 
cascade that regulates a myriad of physiological activities such as cell motility, 
virulence, biofilm formation and growth. This sensing mechanism is mediated 
by various diffusible, chemical signals known as autoinducers that are 
putatively produced by the synthase gene of the bacteria. The extracellular 
concentration of signalling molecules increases as a function of cell density 
and is permeable to cell membrane, hence allowing an equilibrium 
concentration to be established within cells and the local environment. Upon 
attaining a threshold concentration of chemical signals, the inducers bind to 
specific quorum sensing promoters or associated proteins within cell and elicit 
expressions or repressions of multiple genes, including those that are 
functional for production of autoinducers. Some common examples of 
autoinducers are acyl homoserine lactones (AHLs) that direct gene expression 
in gram-negative bacteria38, oligo-peptides in gram-positive bacteria40 and 
autoinducer-2 (AI-2) that are recognised by both categories of bacteria41.  
 
Both E. coli and P. aeruginosa are gram negative bacteria which utilise acyl 
homoserine lactones as the primary quorum signalling molecules. The first and 
best characterised quorum sensing model of gram-negative microbe is the 
autoinduction of bioluminescence in marine bacterium Vibrio fisheri42. 
Bioluminescence in V. fisheri involves expression of luxR and luxI genes from 
the lux operon which are critical in the production of cellular communication 
proteins: LuxI AHL synthase and LuxR cofactor. The synthase is then 
responsible for the production of autoinducers via the fatty acid biosynthesis 
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pathway using S-adenosylmethionine substrate transported by acylated acyl 
carrier protein (Figure 2-3)43. Similar production mechanisms are also present 
in other gram-negative bacteria, with each LuxI homolog producing AHL that 
differs in either length or functional groups (hydroxyl, carbonyl or hydrogen 
atoms) on the acyl side-chain. Thus, with each bacterium possessing 
disparate synthase sequence, a high level of specificity can be achieved 
during intercellular quorum communication. A list of common AHLs with its 
associated species is shown in the Table 2-244, 45.   
 
 
 
Figure 2-3: Biosynthesis of AHL. Two substrates acyl-acyl carrier protein and S-adenosyl-L-
methionine is catalysed by AHL synthase to undergo acylation and lactonization reaction. After 
reaction is completed, the product AHL and regenerated cofactors 5’-methyl-thioadenosine 
and holo-acyl carrier protein are released. The figure is reproduced from 43 with permission. 
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Table 2-2. Autoinducer homoserine lactone in Gram-negative bacteria. The 
table is adapted from 44, 45 
 
Two lux-homolog quorum sensing systems are present in P. aeruginosa: las 
system in combination with 3OC12HSL and rhl system with C4HSL. The las 
system involves a transcriptional activator LasR and autoinducer synthase 
LasI, and regulates the production of virulence factors such as elastase, LasA 
protease, exotoxin A46, and secretory proteins encoded by xcpP and xcpR 
Full Name Molecule Abbreviation Species Chemical formula 
Butyryl-homoserine 
lactone C4HSL P. aeruginosa 
 
Hexanoyl-
homoserine lactone C6HSL 
C. violaceum 
R.  solanacearum  
Heptanoyl-
homoserine lactone C7HSL E. psidii 
 
Octanoyl-
homoserine lactone C8HSL 
B. cepacia, 
V. fischeri  
Decanoyl-
homoserine lactone C10HSL 
C. violaceum 
B. pseudomallei 
 
3-oxohexanoyl-
homoserine lactone 3OC6HSL 
V. fischeri 
Y.  pseudotuberculosis 
 
3-oxoctanoyl-
homoserine lactone 3OC8HSL A. tumefaciens 
 
N-3-oxododecanoy-
homoserine lactone 3OC12HSL P. aeruginosa 
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genes47. This quorum sensing system is positively regulated by factors GacA48 
and Vfr that is required for the transcription of LasR protein49, and negatively 
regulated by RsaL that suppresses transcription of LasI synthase50.  The rhl 
system comprises of RhlR transcriptional regulator and RhlI synthase which 
generates C4HSL with some subtle production of C6HSL.  It is activated after 
initiation of las system and controls the expression of rhlAB operon that 
encodes for rhamnosyltransferase to synthesize rhamnolipid, a biosurfactant 
that emulsify hydrocarbon substrate for utilization by the cells51. Interestingly, it 
has also been shown that the expression of rhlAB operon is repressed by 
other regulatory components during the exponential phase even in the 
presence of C4HSL and RhlR52, suggesting that genes regulated by rhl system 
also involve las system for complete expression53. The rhl quorum sensing 
system is known as vsm (virulence secondary metabolites) as it also regulates 
the expression of virulence factors LasA, LasB and pyocyanin54, 55.  
 
Uptake and secretion of C4HSL and 3OC12HSL differs due to disparate 
molecular length and hydrophobicity of substituent groups; C4HSL is freely 
diffusible through cell membrane while 3OC12HSL requires an active efflux 
system56. Studies have shown that the combination of autoinducer and its 
respective R-proteins are highly specific in terms of transcriptional activity57 i.e. 
C4HSL will not activate LasR protein and vice versa and the resultant activator 
complex are sensitive to only specific promoters. It is however important to 
note that neither system is completely independent of each other. Figure 2-4 
illustrates cellular communication cascade in P. aeruginosa and the 
interdependency between lasR/3OC12HSL and rhlR/C4HSL quorum sensing 
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2.3 Pyocins of P. aeruginosa  
Pyocin treatment strategy was inspired by bacteria’s most primitive attempt in 
securing its survival in a competitive environment alongside other bacteria 
strands by means of ribosomally-synthesized antibacterial peptides or 
bacteriocins.  First discovered by Francois Jacob in 1954, pyocins are narrow-
spectrum bacteriocins produced by clinical isolates of P. aeruginosa and 
termed after the species former name: Pseudomonas pyocyanea59. 
Bacteriocins are specific and effective against proximal species and thus have 
garnered attention in the medical engineering application as the new 
generation antimicrobial molecules60.  Most discoveries associated with 
natural pyocin production have been derived from studies of P. aeruginosa 
strand PAO1.  Pyocins can be classified into 3 types61. The R and F types are 
distinguished by their rod like morphology, bearing similarity to bacteriophage 
tails that have evolved and specialised as antibacterial peptide (Figure 2-5). 
With both classes of pyocin being resistant to protease and nuclease activities, 
the only distinct difference between R and F type hinges upon the higher 
degree of flexibility encountered in the F type. The S type was first discovered 
by Ito and Kageyama with an isolate of P. aeruginosa that was known to 
produce R type pyocin62. The isolate was treated with anti-R serum and 
spotted for inhibition studies. Results showed broader inhibition zone, 
confirming that the same P. aeruginosa isolate was capable of secreting a 
plethora of pyocins. Studies by Smith estimated that R and F type pyocins are 
synthesized by 90% of all P. aeruginosa strains and S type by 70% of them63.   
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protein is regarded as the immunity protein that confers the host cell with 
defence mechanism against its own pyocin65, 66. Pyocin S1, S2, S3 and AP41 
initiate cell death in other P. aeruginosa strands through endonuclease action 
of the C terminus of the larger protein, with the killing activity of S1 and S2 
larger than AP4167.   
 
Genomic analysis of S4 and S5 coding sequence predicted ternary structures 
that are analogous to tRNase and pore forming proteins68. Pyocins, in 
particular pyocin S5, present great potential in the treatment of P. aeruginosa 
infection for the following reasons: (1) pyocin S5 is soluble and can be readily 
overexpressed in engineered probiotic E. coli without compromising 
survivability of the producing host bacteria. (2) Pyocin S5 acts by forming 
pores on the membrane of P. aeruginosa and does not need to be 
translocated into the pathogen interior, thereby avoiding the mechanism of 
antibiotic efflux pumps. (3) Unlike other bacteriocins such as colicin, the 
immunity genes of pyocins are encoded in the chromosome of pyocin-
producing Pseudomonas instead of plasmid vectors as encountered with most 
bacteriocins. Consequently, development of pyocin resistance by lateral gene 
transfer has not yet been encountered to date. (4) Pyocin bactericidal activities 
are specific to P. aeruginosa and will not target other commensal bacteria that 
are vital to human health69. Together with its characteristics of being soluble 
and small at 498 amino acids, S5 is an ideal pyocin for treatment against P. 
aeruginosa infection.  
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Table 2-3. S-type pyocins from PAO1.  
S Type Pyocin Mode of Killing Reference 
S1 DNase  65 
S2 DNase  65 
S3 DNase  70 
S4 tRNase  68 
S5 Pore forming 68, 69 
AP41 DNase  71 
 
 
2.4 Designing Biological System through Synthetic Biology 
Synthetic biology is the application of engineering science to the systematic 
design of biological systems – using the design, build, test and analyse 
paradigm72. This enables the artificial design and assembly of functional 
biological systems that can be readily applied towards solving contemporary 
problems facing the world. Thus far, synthetic biologists have demonstrated 
that this design framework can be applied to advance applications in energy, 
environment and healthcare. Particularly, novel biological systems have been 
constructed to produce isoprenoid- and alkaloid-based drugs26, 27 and 
biofuels23-25, to restructure the gut microbiota28, and to treat cancer29.  
 
One global crisis that has been partially relieved through synthetic biology-
driven technology is the control of malaria caused by the protozoan 
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Plasmodium. Malaria is estimated to cause annual deaths of more than 3 
million with worldwide contagion of 500 million. Although the drug artemisin 
has been proven to be effective in the treatment against malaria, current 
methods of production are too expensive to be considered economically 
feasible in ameliorating the effects felt in developing Sub-Saharan Africa. In 
2006, Keasling and colleagues successfully produced artemisin precursors in 
metabolically engineered yeast26. This biotechnology allows the cost of 
artemisin to be drastically reduced from US$2.40 to US$0.25 per dose. 
Synergetic applications of synthetic biology and systems metabolic 
engineering have also lead to the advancement of biofuel research by 
incorporating novel metabolic pathways for fuel production into an engineered 
microbe in 201023.  
 
Disruption to a healthy gut flora has been linked to the pathogenesis of 
inflammatory bowel disease, chronic diarrhoea, colitis and other irritable bowel 
syndromes73. One established method to restore a healthy gut flora is through 
faecal microbiota transplantation of stool bacteria harvested from healthy 
donor74. In 2014, a novel method to engineer the human microbiome with 
CRISPR-Cas technology was introduced (Figure 2-6)28.  CRISPR-Cas is an 
adaptive prokaryotic defence strategy to reject undesired mobile genetic 
elements75. By redesigning the spacer sequences of CRISPR RNA (crRNA) to 
complement specific genetic signature, the cas9 endonuclease was guided, 
with the support of trans-activating CRISPR RNA (tracrRNA) to introduce 
double strand break in target genes that encoded for antibiotic resistance. This 
microbiome engineering technology successfully attenuated 
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Enterobacteriaceae and enterohemorrhagic E. coli infections in G. mellonella 
infection model.  
 
 
Figure 2-6: Engineering of human microbiome through selective destruction of pathogenic 
genetic signature. The figure is adapted from 28 with permission. 
 
The construction of functional biological systems involves development of 
standard biological parts, popularly termed as “Biobricks”. Biobricks are 
functional modular DNA sequences that are held in circular standardised 
plasmid vectors. Standardisation enables synthetic biologists to ligate various 
Biobrick parts together to form biological “devices” which are capable of 
performing a user-defined functions such as production of certain recombinant 
protein. Finally, a myriad of biological devices could be incorporated 
simultaneously into microbe cell chassis to perform more sophisticated tasks. 
This approach can be applied to generate novel biosensors for any molecules 
and the coupling of multiple environmental cues through design of biological 
logic gates pronounces specificity of the detection system. Thus, by regulating 
Drug-resistant 
plasmid destruction
RGN (RNA-guided nuclease) system injected into
pathogen using engineered virus or conjugative bacteria
crRNA and tracrRNA recognize 
DNA signature and recruit cas9 
nuclease (Cell Death)
chromosome disruption
RGN-tRNA-crRNA
RGN-tRNA-crRNA
cas9 nuclease 
inactive if target 
DNA signature 
is absent
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the production of functional proteins under transcriptional or translational 
sensing elements, living cells can remodelled into powerful micro-robots for a 
myriad of constructive applications. 
 
Biobricks can be broadly classified into 4 categories by its function: promoter, 
ribosomal binding site (RBS), protein coding sequence and terminator. The 
promoter allows RNA polymerase to bind and initiate transcription upon 
detection of the transcription start site. Ribosomal binding site encodes genetic 
information for the binding of ribosomal subunits on mRNA transcript to 
activate translation. Protein coding sequences code for functional proteins that 
is largely associated with the application of interest. Terminator sequences 
stop transcription by forming a hairpin secondary structure that disrupts the 
DNA-mRNA-RNA polymerase ternary complex. Biobricks are standardised by 
designing each part to be flanked by precise ‘‘prefix’’ and ‘‘suffix’’ sequences. 
The prefix consists of restriction sites EcoRI, NotI and XbaI while the suffix 
consists of restriction sites SpeI, NotI and PstI. XbaI and SpeI are 
isocaudomeric, possessing different restriction enzyme recognition site but 
generate similar termini upon cleavage (Figure 2-7). The introduction of XbaI 
and SpeI in prefix and suffix sequences enable biobricks, cleaved individually 
by XbaI and SpeI, to anneal and form longer composites and devices76. In 
2010, another standardised assembly method – the BglBrick assembly 
standard, was created using a different set of isocaudomeric restriction sites 
(EcoRI, BglII, BamHI and XhoI)77. By comparison, the BglBrick assembly 
involves restriction enzymes that are unaffected by overlapping dam or dcm 
methylation and cut as effectively as the Biobrick restriction sites. However 
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systems. Decoupling and abstraction hierarchy assumes that the development 
of a synthetic biological system can be redefined and modelled 
computationally in terms of system complexity. That is, an overall system is 
composed of several independent sub-systemic biological devices which are in 
turn assembled from orthogonal and modular biological parts. This engineering 
approach allows synthetic biologists to rationally design and construct 
biological systems without regards to specifications at other levels. Recent 
advents in synthetic biology have provided a unified foundational methodology 
for conducting characterisation experiments of biobrick parts76, 79. Published 
works at present include the measurement of promoter activity for constitutive 
and inducible promoters, functional biological logic gates and quorum sensing 
elements, all of which are strategic tools in either transcriptional control or inter 
cellular communication. 
 
2.5 Synthetic Gene Circuits and Logic Devices 
One key aspect of synthetic biology is the engineering of biological networks80. 
Genetic circuits are evolutionarily adapted by cells to coordinate diverse 
biological properties including metabolism and growth81, 82, cell cycle83, biofilm 
differentiation84, cell-cell signalling85, motility86, virulence87, 88, competitive 
fitness89, 90, and molecular transport91, 92. By and large, our current knowledge 
of genetic circuits and network topologies are acquired through a top-down 
systems biology approach which involve the genetic perturbations of model 
systems complemented with de novo mathematical and computational 
modelling93. While these approaches have been effective in presenting a 
holistic understanding of cellular interaction maps, questions such as why 
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certain genetic architectures are preferred or ways to modify the sensitivity and 
specificity of input-output relationships of genetic circuits remain unanswered. 
Synthetic biology provides an alternative approach to understanding biology 
through the bottom-up design and assembly of simple, well-characterised 
genetic components into synthetic gene circuits. In the words of esteemed 
Nobel Prize winner Richard Feynman (1988), “what I cannot create, I do not 
understand”. Thus far, the synthetic biology design framework has been 
successfully applied to construct genetic circuits that enabled operations of 
genetic toggle switches94-96, oscillators95, 97-99, bandpass filter100, genetic 
amplifier101-103, genetic clocks104, 105, edge detector106, pattern generators107, 108, 
cellular counter109 and memory devices101, 110.  
 
Design of robust and functional genetic circuits are more challenging as 
compared to conventional genetic engineering that requires minimal genetic 
manipulation111, 112. In several studies, synthetic gene circuits failed to operate 
as desired when the preliminary design conditions were imbalanced94, 95, 108, 113.  
That is, for coupled genetic circuits to generate the desired response at the 
system level, component regulators have to be precisely tuned to synchronise 
their behaviour with other modules of the system. This obstacle may be 
resolved through optimisation of genetic circuits with accurate modelling, parts 
libraries and directed evolution, although directed evolution is difficult to 
implement for oscillatory circuits without definite ON-OFF digital 
performance114-118. Second, modules that make up the genetic circuits have to 
be orthogonal and function independently when combined. In this respect, 
genome ‘parts mining’ have been applied to obtain novel biological parts from 
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unrelated microorganisms119, 120. These biological parts are then extensively 
characterised or mutagenised to be orthogonal to chassis and other parts. 
Third, coupled genetic circuits may be subjected to “retroactivity” if component 
regulators at low quantity are sequestered to high-affinity promoters in 
downstream circuitry, resulting in changes to the dynamics of upstream 
modules78. This effect can be significant in the case of oscillatory systems or in 
systems with both parallel and serial circuits. Del Vecchio and colleagues 
analysed the input-output dynamic characteristics of transcription regulators 
and suggested that the implementation of a feedback amplification loop to the 
upstream generation of the regulators may attenuate the effect of 
retroactivity121, 122. Fourth, the performance of synthetic gene circuits can be 
affected by environmental, cellular and genetic context dependent effects 
including nutrient availability, aeration, toxic interactions, nitrogen and carbon 
metabolism, resource allocations and genetic architecture123-126. In this respect, 
orthogonal genetic modules can be independently characterised in the same 
cellular and environmental context before being interfaced together to enable 
better predictability of the engineered biological system127. Additionally, RNA 
processing enzymes have been shown to be effective buffers against 5’ 
untranslated region genetic-context dependent effects128, 129. Nonetheless, 
much awaits to be discovered in this largely unexplored domain of synthetic 
biology.  
 
Synthetic biological systems can be designed to perform analog or digital 
computation, or a combination of both as observed in natural systems130, 131. 
Analog genetic circuits enable the processing of graded information with less 
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devices and lower consumption of cellular resources80. By comparison, digital 
genetic circuits are significant in situations when decision making is required132. 
Daniel et. al. presented the first synthetic analog circuit by rewiring the amount 
of transcription factors to be logarithmically linear over broad range of inducer 
concentration (Figure 2-8). This was achieved through two features in the 
engineered circuit: (1) A positive feedback loop on a low copy plasmid to 
produce transcription factor (TF), thereby offsetting the saturated binding of 
inducer to TF, and (2) exacting the expression of output reporter under the 
control of TF in (1) on a high copy plasmid, thereby offsetting the saturation of 
promoter DNA binding sites. That is, the availability of DNA binding sites was 
designed to be in excess of inducer-TF complex and the availability of TF was 
designed to be non-saturating over the range of inducer added. In contrast, a 
control circuit without positive feedback loop to offset saturated inducer binding 
displayed nearly digital behaviour. Finally, the authors demonstrated that basic 
log-linear modules could be linked in various manner to achieve advanced 
analog operation, including multiplication, negative log and power law 
functions. Notably, these were achieved with only two transcription factors in 
each circuit, saving precious cellular resources.   
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Figure 2-8: Synthetic gene circuits. (A) Graphical representation of analog and digital outputs. 
Analog genetic circuits process information over wide range of inputs while digital circuits 
discretize minima and maxima outputs as OFF and ON logics. (B) Simplified schematic of 
analog genetic circuit designed by Daniel et. al (2013). The figure is adapted from 132 with 
permission.  
 
Digital genetic circuits are commonly associated with genetic switches and 
logic gates. A biological logic gate is a genetic interface that integrate and 
process input signals from two or more inducible genetic devices into a 
specific output signal (control of a cellular response). In 2007, the first 
biological AND gate was developed by Anderson et. al. to enhance the 
specificity of whole-cell biosensor133.  In this design, an input switch device 
(activated by input A) was used to regulate the expression of T7 RNA 
polymerase (T7RNAP) modified with two amber stop codons in the middle of 
their genes. Because T7RNAP are viral RNA polymerases, they are 
orthogonal to intrinsic genetic networks in host bacteria systems and are 
strong transcription drivers. A second input switch (activated by input B) was 
used to regulate the expression of supD which enabled the proper translation 
of T7RNAP. In particular, SupD tRNA mediates the translation of amber stop 
TF
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Low copy 
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Reporter
Inducer
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Digital OFF
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A B
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codons into serine residues instead of stopping translation. Therefore, in the 
presence of both input A and B, functional T7RNAP would be produced to 
trigger the downstream expression of green fluorescent reporter (GFP) placed 
under the control of cognate pT7 promoter.  In the presence of only input A, 
T7RNAP translation would be terminated prematurely. Likewise, the presence 
of input B alone would not permit the expression of T7RNAP transcript. Thus 
in both situations with only singular input, GFP was not observed.  
 
Advances in structural and molecular biology studies of T7RNAP revealed that 
nicked N- (1-179) and C-terminal (180-880) fragments of T7RNAP could be 
non-covalently refolded into a functional protein during transcription initiation 
and that the binding specificity of T7RNAP to pT7 promoter library was 
dictated by a core region in the C terminus134-137. In 2013, Shis and Bennett 
exploited these properties to develop three transcriptional AND gates that 
were comparatively orthogonal to one another using mutant split T7RNAP138. 
Importantly, this study shows that proteins which participate in DNA 
transcription could be engineered by fragmentation and mutagenesis to 
generate orthogonal logic gates, thereby expanding our capacity to program 
biological systems.  
 
In 2014, Schaerli et. al. noted that simply relying on the non-covalent assembly 
of split T7RNAP led to reduced transcription activity and adopted a different 
approach to engineer split T7RNAP AND gate. Using a split-intein splicing 
strategy that had earlier been demonstrated for engineering logic gates in 
mammalian cells139, 140, the split fragments of short-lived T7RNAP were fused 
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to Npu and Ssp DnaE inteins from Nostoc punctiforme and Synechosycystis 
spp. to develop intein-spliced T7RNAP AND logic gate. In the presence of two 
inputs, split T7RNAP fragments generated from independently regulated 
genetic switches undergo post-translational protein splicing to restore a 
covalently repaired T7RNAP, resulting in gene expression from pT7 promoter. 
 
Biological AND gates can also be designed using promoters that require 
specific chaperone-transcription activator pair to elicit DNA transcription. In this 
respect, two studies have separately explored the genetic regulatory systems 
in pathogenic bacteria type III secretion system (T3SS) to develop modular 
and orthogonal AND logic gates in layered genetic circuits120, 127.  
 
In 2011, Wang et. al. developed a functional AND logic gate in E. coli using 
codon-optimised chaperone and transcription activator isolated from the hyper 
sensitivity and pathogenicity regulon (σ54-dependent HrpRS transcription 
system) in P. syringae127. To achieve this, a library of synthetic gene circuits 
were assembled and extensively characterised to optimise the production rate 
of HrpR and HrpS transcription activators, thereby enabling near-digital 
performance of the biological AND gate. The authors also introduced a NOT 
gate module downstream of the HrpRS AND gate module to generate NAND 
logic outputs, thus presenting a modular approach to engineer genetic circuits.  
 
Elsewhere, Moon et. al. looked to T3SS genomic clusters in Salmonella 
typhimurium, Shigella flexineri and P. aeruginosa for novel biological parts to 
develop three modular AND gates120. To mitigate potential crosstalk between 
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AND gate modules and expand the dynamic range one of the AND gate 
promoter, directed evolution was applied to SicA chaperone and -10 region of 
pipaH promoter gene using saturation mutagenesis. The authors 
demonstrated orthogonality and robustness of the AND gate modules by 
layering them all together to perform 4-input AND logic operation, one of the 
finest synthetic gene circuits ever created in prokaryotic cell. Impressively, the 
4-input AND digital circuit was built with 11 regulatory proteins and 3 AND gate 
modules that assimilated and processed input signals from 4 genetic switches.   
Genetic circuits with OR logic operations can be designed either by placing 
inducible promoters in tandem arrangement, or by regulating the expression of 
target gene in discrete expression cassettes.  
 
In 2011, Tamsir et. al. successfully created three OR logic modules out of 
pBAD, pTET and pLAS promoters by positioning any two out of three inducible 
promoters in tandem141. To demonstrate versatility of the engineered OR gates, 
genetic NOT logic modules comprising of λCl repressor and pλCl promoter 
were then coupled downstream of OR modules to achieve single cell NOR 
logic operation. Using quorum sensing as chemical “wires” to mediate signal 
transduction between cells, NOR and NOT gate modules in 4 different cell 
population were connected into a synthetic cellular consortia with XOR 
computing power (Figure 2-9). Importantly, the work demonstrated how 
synthetic biology principles could be applied to program distributed 
computations in single cells, which could then be networked to meet higher-
ordered objectives through cell-cell communication and division of labour.  
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Figure 2-9: Simplified schematic of multi-cellular computing system connected by quorum 
sensing communication. The figure is reproduced from 141 with permission. 
 
Alternatively, unidirectional recombinases can be used to program digital 
performance in prokaryotic cells with memory. In 2012, Siuti et. al. successfully 
programmed E. coli cells to perform up to 16 different types of two-input 
Boolean logic functions with only Bxb1 and phiC31 serine recombinases110. 
Specifically, inducible switches were used to regulate the expression of the 
Bxb1 and phiC3 recombinases, the production of which would catalysed 
irreversible site-specific DNA inversion. By flanking constitutive promoters, 
gene coding sequences and terminators with specific inversion sites 
recognised by target serine recombinases, robust and efficient DNA inversion 
could be effected. Cells programmed by serine recombinases retained DNA-
encoded memory for at least 90 cell generations, providing a resourceful 
platform for therapeutic and diagnostic biotechnology142.  
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Chapter Three 
3. METHODOLOGY 
Synthetic biology principles have been applied to program human commensal 
microbe with novel molecular functions in simple plug and play mode.  
 
In Section 3.1, the methods that were performed to assemble, characterise 
and evaluate the effectiveness of the engineered microbe in multi-cellular 
systems will be discussed.  Specifically, the respective genetic modules that 
enabled the engineered E. coli to sense, lyse and release antimicrobial peptide 
pyocin S5, and the bactericidal activity of pyocin S5 were independently 
characterised. The effectiveness of the engineered E. coli in controlling the 
population of a clinical isolate of P. aeruginosa when both bacteria population 
were cultured together were also studied.   
 
Section 3.2 describes the methods which were used to develop and 
characterise genetic logic gates that enabled engineered E. coli to function as 
biological microprocessor, including AND, OR, IMPLY, XOR, half adder and 
half subtractor logic operations. The logic gates develop in this study enabled 
E. coli to process multiple biosensing input signals and elicit the desired 
molecular responses, thereby allowing greater specificity in diagnosis and 
treatment.   
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Lastly, Section 3.3 describes a list of troubleshooting tips that can be applied 
to overcome certain experimental difficulties, such as cloning genetic parts 
with rich hairpin structures or to obtain microscopic images of better resolution. 
Part of this chapter was published in Springer Protocols, Humana Press143. 
Additional supplementary information is presented in appendix A. 
 
3.1 Therapeutic Microbe against Pseudomonas Infection 
3.1.1 Design of Therapeutic Microbe against P. aeruginosa  
 
 
Figure 3-1: Schematic of Pseudomonas Sense and Kill system. 3OC12HSL signalling 
molecules are intercepted and recognised by the sensing device of the engineered E. coli, 
leading to subsequent expression and production of Pyocin S5 and E7 lysis protein. 
Accumulated pyocin S5 are released into the extracellular environment when E. coli host 
lysed itself, resulting in the eradication of P. aeruginosa. The figure is reproduced from 144  
with permission. 
Choon Kit Wong et al. in Engineering and Analyzing Multicellular Systems, Vol. 1151. (eds. L. Sun 
& W. Shou) Springer New York, 117- 133 (2014). 
 
39 
 
 
 
To expand the ability of gut microbes to defend against P. aeruginosa infection, 
commensal bacteria could be repurposed with novel functions that enabled 
them to sense quorum sensing molecules from P. aeruginosa, synthesize 
killing molecules which are specific to the pathogen, and release the 
accumulated killing molecules through self-lysis to eradicate the pathogen144. 
Thus, to develop a synthetic biological system with such high level 
specifications, E. coli was genetically reprogrammed with sensing, killing and 
self-lysis modules. Figure 3-1 shows a schematic of the sensing and killing 
genetic system.  
 
The sensing device was designed based on the more dominant Type I quorum 
sensing mechanism of P. aeruginosa. The tetR promoter, which is 
constitutively on, produces a transcriptional factor, LasR, that binds to AHL 
3OC12HSL. The luxR promoter, to which LasR-3OC12HSL activator complex 
reportedly binds, was adopted as the inducible promoter in the sensing 
device145. Importantly, previous studies had estimated extracellular 
concentration of 3OC12HSL to be between the ranges of 1E-06 to 1E-04 within 
proximity to the site of infection146, 147. 
 
We utilised E7 lysis protein to lyse the E. coli chassis. The E7 lysis protein is a 
key component of the SOS response system in colicin-producing cells and 
functions to export bacteriocins into the extracellular space under stressful 
environmental conditions148. Recent studies have shown that the E7 lysis 
protein is effective in causing inner membrane damage and maybe associated 
with the activation of outer membrane phospholipase A (OMPLA) for outer 
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membrane modification149. Formation of the LasR-3OC12HSL complex, which 
binds to the luxR promoter, activates the killing and lysing devices, leading to 
the production of pyocin S5 and E7 lysis proteins within the E. coli chassis.  
Upon reaching a threshold concentration, the E7 lysis protein perforates 
membrane of the E. coli host and releases the accumulated pyocin S5. Pyocin 
S5, which is a soluble protein, then diffuses toward the target pathogen and 
damages its cellular integrity, thereby killing it.  
 
3.1.2 Gibson Assembly 
Gibson assembly is an isothermal ‘multi-pot’ cloning technique that harnessed 
the collective enzymatic actions of T5 exonuclease, Phusion DNA polymerase 
and Taq DNA ligase to assemble genetic constructs of up to several hundred 
kilobases. Originally developed for the assembly of synthetic genomes, it is 
now widely used for fast and efficient pathway reconstruction150. In this 
demonstration, the final system (QS-S5-E7) was constructed using a 
customized protocol of Gibson assembly technique (Figure 3-2). 
1. An in silico design of the overall genetic construct was performed on a 
plasmid drawing software. 
2. Primers for PCR amplification of linear inserts and vector were designed 
and synthesized to achieve fragment sizes of 300 bp – 5 kb (see Note 2). 
Of note, primers were designed to incorporate between 20 bp – 40 bp of 
overlapping sequences. Spacer sequences were added where necessary 
(see Note 3,4). 
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3. PCR reaction tubes were set up on ice as described in Table 3-1. Phusion 
High-Fidelity DNA polymerase were used for the amplification of long DNA 
fragments. 
4. PCR reactions were performed in a thermocycler with cycling conditions as 
described in Table 3-2. Of note, successful PCR products were generated 
using a two-cycle PCR approach. During the first cycle, DNA template was 
enriched for 5 cycles by using the Tm which overlapped with the source 
DNA template to determine the annealing temperature. The second cycle 
adopted a higher Tm of the enriched template for more specific priming of 
target amplificons. Here, I demonstrate the amplification of three DNA 
fragments using source templates from open plasmid repository, with sizes 
of 2.8 kb (QS-S5), 320 bp (E7) and 3.5 kb (vector).  
5. The amplified DNA fragments were separated on a 0.8% w/v agarose gel 
by gel electrophoresis (85 V, 45 min).  
 
Table 3-2. PCR cycling conditions 
6.  
Cycle No. Denaturation Annealing Extension 
1 98 °C, 30 s   
2 –  6 (1st cycle) 98 °C, 10 s Tm1 + 3 °C, 30 s 72 °C, 15 s/kb 
7 – 26 (2nd cycle) 98 °C, 10 s Tm2 + 3 °C, 30 s 72 °C, 15 s/kb 
27   72 °C, 5× of extension 
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7. DNA bands of interests were visualised on a blue light transilluminator and 
isolated with a sterile scalpel. The isolated DNA fragments were then 
purified with QIAquick Gel Extraction Kit according to vendor’s instruction 
and analysed with Nanodrop. Of note, good DNA concentrations above 
20ng/µl were ideal for efficient Gibson assembly reactions (see Note 5). 
Purified DNA fragments were kept in ice bath until use.  
8. A 15 µl aliquot of 1.33× assembly master mix was thawed on ice for 5 min.  
9. Equimolar amounts of DNA inserts and vector (total DNA concentration of 
up to 100 ng) were added to 15 µl of assembly master mix. Nuclease-free 
water were then added to a total reaction volume of 20 µl. 20 ng of 
linearized vector DNA was used during the assembly process. The amount 
of insert required could be empirically calculated by Eqn. 3.1.  
Mass of insert(ng) 
=
Lengthofinsert (bp)
Lengthofvector (bp)
× Massofvector(ng)                                    𝐄𝐪𝐧. (3.1) 
10. The reaction mixture was incubated at 50 °C in a thermocycler with heated 
lid for 1 h. The temperature inversion was necessary to avoid evaporation 
and the consequential loss of enzymatic activity. On completion, the 
reaction tube was held on ice for at least 15 min.  
11. Next, 50 µl aliquot of chemically competent E. coli cells were thawed for 5 
min on ice. 5 µl of the reaction mixture were then transformed into E. coli 
cells by 45s heat shock at 42 °C and 5 min incubation on ice. 400 µl of 
prewarmed SOC were added. Following, the entire transformation culture 
was transformed to a sterile round bottom capped tube and incubated in a 
shaking incubator set at 225 rpm and 37 °C for 40 min.  
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12. After transformation, 1/5 of the culture (~100 µl) were spread on an 
antibiotic-selective plate. The remaining 4/5 of the culture were diluted in 
100 µl of SOC and plated on another antibiotic-selective plate.  
13. Plates were incubated in a 37 °C incubator for 15 h and screened the next 
day by colony PCR. 
 
3.1.3 Characterisation of Quorum Sensing Device 
To evaluate the sensitivity and range of the quorum sensing device in an E. 
coli host, we cloned a GFP reporter downstream of the sensing device (QS-
GFP) and measure the fluorescence output after induction with synthetic 
3OC12HSL molecule. Consequently, the characterisation profile of this 
biosensor can be used to estimate the amount of 3OC12HSL that is secreted 
by P. aeruginosa clinical isolates. M9 medium was supplemented with 
appropriate antibiotic throughout this experiment unless otherwise stated. 
1. A single colony of E. coli with the plasmid QS-GFP was inoculated from a 
fresh plate into 5 ml of M9 characterisation medium. Following, the culture 
was incubated in a 37 °C shaking incubator set at 225 rpm for 15 h. 
2. After 15 h of incubation, the culture was diluted 100× in 10 ml of 
prewarmed M9 characterisation medium. The re-inoculated culture was 
then allowed to grow to OD600 of 1.0 under the same conditions. This 
corresponded to mid-log phase of the cells. 
3. While waiting for the re-inoculated culture to grow to the desired cell 
density, a 96-well microplate was prefilled with 110 µl of fresh M9 
characterisation medium. 3OC12HSL test solutions (0.1 µM, 1 µM, 10 µM, 
0.1 mM and 1 mM) were vortexed evenly. 1 – 2 µl of each 3OC12HSL 
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solution were then added into the media so that the final 3OC12HSL 
concentrations in the 96-well microplate were in the range of 0 – 10-5 M. 
4. Empty wells were filled with 220 µl of M9 characterisation medium to serve 
as both sterility control and liquid reservoir. A column of wells was also 
allocated for zeroing with 220 µl of M9 characterisation medium.  The 
microplate was then prewarmed in a 37°C incubator for 30 min just before 
use. Of note, the microplate was covered with lid and sealed tight with 
parafilm when outside a biological hood or Bunsen flame. 
5. The Synergy HT Multi-Mode Microplate Reader was prepared for end-point 
measurement of absorbance (OD600) and fluorescence (485 nm excitation / 
528 nm emission) at regular intervals of 5 min, with 30 s of rapid shaking 
before sampling. Temperature was set to 37 °C. Advance users could 
further program Biotek’s Gen5 Data Analysis software to obtain triplicate 
average of background subtracted fluorescence per OD600. Otherwise, data 
analysis could be performed in an exported excel sheet. 
6. On reaching the desired cell density, the reinoculated culture was poured 
into a sterile petri dish. 110 µl of the re-inoculated culture was transferred 
into the prefilled microplate with a multi-channel pipette, effectively diluting 
the culture to OD of 1. The culture was evenly mixed by up and down 
pipetting actions, before being sealed with a transparent sealing film.  
7. The microplate was transferred into the microplate reader and analysed for 
both fluorescence and absorbance for 3 h.  
8. Raw experimental data were then into MS Excel. The fluorescence (RFU) 
and absorbance (OD600) values of each well were normalised by zeroing 
with the average of pure M9 characterisation medium as shown in Eqn. 3.2 
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and 3.3. The relative quantities of GFP molecules in single cells were 
derived as a ratio of background subtracted fluorescence to OD600 values 
(RFU/OD600).  
Normalised Fluorescence of sample x at time t, 
  RFUt
x′ = RFUt
x − RFUt
M9                                                              𝐄𝐪𝐧. (3.2) 
Normalised OD600 of sample x at time t,  
  ODt
x′ = ODt
x − ODt
M9                                                                     𝐄𝐪𝐧. (3.3) 
9. Resultant values of RFU/OD600 were averaged from technical triplicates. At 
least 3 independent experiments were performed in this study. Of note, 
only analysed data from independent experiments (biological replicates) 
were used to determine the standard deviations of statistical means. 
10. The GFP production rate (RFU.OD600-1min-1) was derived by taking the 
difference of RFU/OD600 values from two time-points and dividing the result 
by the time interval δt as shown in Eqn. 3.4.   
GFP Production Rate of sample x at time t,    
RFU
OD ∙ t 
   =  
RFUt+δt
x′ ODt+δt
x′ − RFUt
x′ ODt
x′⁄⁄
δt
                              𝐄𝐪𝐧. (3.4) 
11. Analysed data was ploted on a 3D plot using Matlab, setting 3OC12HSL 
concentration, time and GFP production rate as the x-y-z axis respectively. 
12. The period to which steady state GFP production rate was observed was 
determined with the 3D graphical plot obtained in Step 10. The mean GFP 
production rate were then calculated by averaging the numerical values of 
all GFP production rates within this identified period (see Note 6). The 
experimental results were then fitted to an empirical mathematical model 
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as shown in Eqn. 3.5 using Matlab Curve Fitting Toolbox where A, B, C 
and n were curve-fitted empirical parameters. 
GFP Production Rate,      
Y = A +
B [3OC12HSL]
n
Cn + [3OC12HSL]n
                                                          𝐄𝐪𝐧. (3.5) 
 
3.1.4 Estimation of Native Autoinducer Produced by P. aeruginosa 
This protocol describes a method to measure the extracellular homoserine 
lactone  produced by P. aeruginosa clinical isolates using the engineered 
biosensor QS-GFP151.  
1. A single colony of E. coli carrying QS-GFP was inoculated into 5 ml of M9 
characterisation medium separately. The culture was then incubated in a 
37 °C shaking incubator set at 225 rpm for 15 h.  
2. Step 1 was repeated to grow all P. aeruginosa isolates separately. 
3. After 15 h of incubation, the E. coli culture was diluted 100× in 20 ml of 
prewarmed M9 characterisation medium. Re-inoculated cultures of E. coli 
(QS-GFP) were allowed to grow to OD600 of 0.5. Cultures were then held 
on ice until use.  
4. Each P. aeruginosa culture from Step 2 was diluted 100× in 5 ml of 
prewarmed M9 characterisation medium.  Re-inoculated P. aeruginosa 
cultures were grown to OD600 of 1.0, under the same conditions.  Cultures 
were then held on ice until use. 
5. The Synergy HT Multi-Mode Microplate Reader was prepared for end-point 
measurement of absorbance (OD600) and fluorescence (485nm excitation / 
528nm emission) at regular intervals of 5 min, with 30 s of rapid shaking 
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before sampling. Temperature was set to 37°C. Advance users could 
further program Biotek’s Gen5 Data Analysis software to obtain triplicate 
average of background subtracted fluorescence per OD600.Otherwise, data 
analysis could be performed in an exported excel sheet. 
6. 600 µl of each P. aeruginosa culture was filter sterilised with 0.22 µm filter.  
The filtrates were then transferred to a 96-well microplate in aliquots of 100 
µl to generate 1× stocks of P. aeruginosa 3OC12HSL. 0.1× stocks of P. 
aeruginosa 3OC12HSL were obtained by diluting 10 µl of aliquot cultures in 
90 µl of M9 characterisation medium. 
7. 200 µl of re-inoculated E. coli (QS-GFP) culture was transferred into a new 
96-well microplate with a multi-channel pipette. Then, E. coli culture in each 
well was induced with 20 µl of 1× and 0.1× filtrates of P. aeruginosa 
cultures from Step 4. This effectively induced QS-GFP with 10× and 100× 
diluted P. aeruginosa filtrate. 
8. Steps 7 – 10 in Section 3.2.2 were repeated.   
9. The concentration of 3OC12HSL in each P. aeruginosa filtrate was 
determined by using the empirical transfer function equation in Eqn. 5. 
 
3.1.5 Characterisation of Lysis Device 
This protocol describes a method to characterise E7 lysis release device using 
high throughput absorbance assay and Bradford protein quantification. The 
protocol can also be applied to study the dynamics of other lytic systems 
including, bacteriocin release proteins of cloacin DF13, colicin E1, E3, A and D 
phage holin and endolysin proteins. 
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1. Single colonies of E. coli carrying the plasmid QS-E7 and QS-E7-S5 were 
separately inoculated into 5ml of M9 characterisation medium. Each culture 
was incubated in a 37 °C shaking incubator set at 225 rpm for 15 h. 
2. After 15 h of incubation, each culture was diluted 100× in 10 ml of 
prewarmed M9 characterisation medium. The re-inoculated culture was 
allowed to grow to OD600 of 1.0 under the same conditions. This 
corresponded to mid-log phase of the cells. 
3. While waiting for the re-inoculated culture to grow to the desired cell 
density, a 96-well microplate was prefilled with 110 µl of fresh M9 
characterisation medium. 3OC12HSL test solutions (0 µM, 1 µM, 0.1 mM 
and 10 mM) were evenly vortexed Then, 2 µl of each 3OC12HSL solution 
were added in triplicates so that the final 3OC12HSL concentrations in the 
96-well microplate were in the range of 0 – 10-4 M. 
4. Empty wells were filled with 220 µl of M9 characterisation medium to serve 
as both sterility control and liquid reservoir. A column of wells was allocated 
for zeroing with 220 µl of M9 characterisation medium.  The microplate was 
then prewarmed in a 37 °C incubator for 30 min just before use. Of note, 
the microplate was covered with lid and sealed tight with parafilm when 
outside a biological hood or Bunsen flame.  
5. The Synergy HT Multi-Mode Microplate Reader was prepared for end-point 
measurement of absorbance (OD600) at regular intervals of 10 min, with 30 
s of rapid shaking before sampling. Temperature was set to 37 °C. 
Advance users could further program Biotek’s Gen5 Data Analysis 
software to obtain triplicate average of background subtracted fluorescence 
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per OD600.Otherwise, data analysis could be performed in an exported 
excel sheet. 
6. On reaching the desired cell density, the reinoculated culture was poured 
into a sterile petri dish. Next, 110 µl of re-inoculated culture was transferred 
into the prefilled microplate with a multi-channel pipette, effectively diluting 
the culture to OD of 0.5. The culture was evenly mixed by up and down 
pipetting actions, before being sealed with a transparent sealing film.  
7. The microplate was transferred into the microplate reader and analysed for 
absorbance for 6 h.  
8. Raw experimental data were exported into MS Excel. The absorbance 
(OD600) value of each well was normalised by zeroing with the average of 
pure M9 characterisation medium as shown in Eqn. 3.  
9. To characterise the efficiency of the lysis device in mediating pyocin 
release, QS-S5-E7 and QS-S5 plasmids were first labeled with hexa-
histidine tags on the 3’ terminus of S5 gene with Phusion DNA polymerase 
and transformed into E. coli Top10. Overnight cultures of the His-tag 
version of QS-S5-E7 and QS-S5 were then diluted in LB and harvested at 
an OD600 of 0.7. The collected cultures were induced with 1.0E-6 M 
3OC12HSL and incubated for 6 hours in a shaking flask culture set at 37 oC 
and 170 rpm. At regular intervals of 2 hours, cell cultures were drawn and 
filter sterilized. The filtered cultures were mixed with 1/10 volume of 100% 
trichloroacetic acid and incubated on ice for an hour to allow protein 
precipitation, before being washed with an equal volume of acetone. 
Precipitated proteins were reconstituted in 1 ml of reconstitution solvent 
and purified by immobilized metal affinity chromatography using Vivapure 
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miniprep MC according to the manufacturer’s instruction. Finally, purified 
pyocin proteins were analysed by SDS PAGE152 and Bradford assay153. 
 
3.1.6 Electron Microscopy Analysis of E. coli Cytoplasmic Release 
This protocol describes a method to visually inspect the extent of lysis and 
cytoplasmic release of E. coli with scanning electron microscopy. The fixation 
method discussed here can also be used for surface morphology studies of 
other bacteria species.  
1. Single colonies of engineered E. coli (QS-S5-E7) and control E. coli (QS-
S5) were inoculated into cell culture tubes each with 10ml of LB plus 
ampicillin. The cell cultures were incubated in a 37 °C shaking incubator 
set at 225 rpm for 15 hours. 
2. Each culture was then diluted to OD600 ~0.01 in 10 ml of LB plus ampicillin 
and grown to a final cell density of OD600 ~0.5 in the same conditions as 
described above. 
3. Optional. The E. coli cultures were further diluted 10× in 10 ml of LB plus 
ampicillin and grown to a final cell density of OD600 ~0.5 (see Note 7).  
3. Next, both the engineered and control E. coli were induced by adding 2 µl 
of 0.1 mM 3OC12HSL to 2 ml of each culture. The induced E. coli cultures 
were incubated in a 37 °C shaking incubator set at 225 rpm for 2 h. This 
experiment was performed in duplicates. 
4. After 2 h of induction, the optical density of each culture was determined. 
The optical density of control E. coli culture should be significantly larger 
than the engineered E. coli. Next, each sample was transferred to sterile 2 
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ml microcentrifuge tubes and centrifuged at 3000 × g and 4 °C for 10 min. 
The supernatant from each sample was discarded.  
5. The cell pellet from each sample was washed with 1 ml of 0.1 M sodium 
cacodylate and resuspended gently by pipetting. The washed samples 
were centrifuged at 3000 × g and 4 °C for 10min, with the supernatant 
discarded. This washing procedure was repeated thrice. 
6. Primary fixation was performed by gently resuspending the cell pellet 
obtain from Step 7 with 1 ml of 2.5% w/v glutaraldehyde in 0.1 M sodium 
cacodylate. Fixed samples were incubate at 4 °C for 2 h or overnight. 
7. The washing procedures in Step 7 were repeated with 1 ml of 0.1 M 
sodium cacodylate thrice. 
8. The cell pellet obtain from Step 9 was gently resuspended in 0.1 M sodium 
cacodylate (10 – 50 µl) (see Note 8).  
9. PEI-coated silicon slide was then placed on a sterile petri dish with a 
tweezer.  
10.  2 µl of engineered cell culture (QS-S5-E7) from Step 10 was spotted on a 
predefined edge of a PEI-coated silicon slide. Similarly, 2 µl of control cell 
culture without the lysis device (QS-S5) was spotted on the edge 
diagonally across the same slide. The petri dish was covered with lid and 
incubated at 25 °C for 30min.  
11. Optional (secondary fixation). The loaded slide was immersed into a well 
on 24-well microplate that contained 1 ml of 1% w/v osmium tetraoxide in 
0.1 M sodium cacodylate and incubated at 25 oC for 90 min (see Note 9).  
12. Other wells on the 24-well microplate were filled with 1 ml of ethanol 
solution at various concentration v/v (37%, 67%, 95%, 100%, 100% and 
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100%). The loaded silicon slide was then dehydrated by immersing the 
slide in serial concentration of absolute ethanol. Dehydration was 
implemented at 25 °C for 15 min (see Note 10, 11). 
13. The slide was subsequently dried in a vacuum dryer overnight set at 25 °C. 
14. The biological samples were coated with 20 nm of gold-palladium alloy with 
an osmium plasma coater and examined using a field emission scanning 
electron microscope at 10 kV. 
 
3.1.7 Overlay Inhibition Assay  
The overlay inhibition assay described here provides a method for the in vitro 
evaluation of antimicrobial efficacy of pyocin produced and released by an 
engineered E. coli. The protocol may be modified accordingly to identify the 
minimum inhibitory concentration (MIC) of other antimicrobial compounds69. 
1. Single colonies of P. aeruginosa isolate In7, engineered E. coli (QS-S5-E7) 
and control E. coli (QS-S5) were inoculated into cell culture tubes each with 
10 ml of LB plus ampicillin. The cell cultures were incubated in a 37 °C 
shaking incubator set at 225 rpm for 15 h. 
2. Each culture was then diluted to OD600 ~0.1 in 10 ml of LB plus ampicillin 
and grown to a final cell density of OD600~1.0 in the same conditions as 
described above.   
3. 10 ml of In7 culture was separated into 2 ml and 8 ml cultures, respectively. 
Re-inoculated E. coli cultures (QS-S5-E7 and QS-S5) and 2ml culture of 
In7 culture were then held on ice until use. This procedure prevented 
growth and preserved a constant cell density temporarily. 
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4. 8 ml of the re-inoculated In7 culture was centrifuged at 3000 × g for 10 min. 
The supernatant was sterilized with a 0.2 µm membrane filter, and the 
filtrate was then transferred into a labelled round bottom capped tube. 
Filtered supernatants containing 3OC12HSL from P. aeruginosa could be 
stored at -20 °C for up to a week. 
5. Engineered and control E. coli cells were harvested by centrifuging each 
culture at 3000 × g for 5 min and discarding the supernatants. Both the 
engineered and control E. coli were then induced by adding the same 
volume of filtered In7 supernatant as the discarded supernatant of E. coli in 
new culture tubes. The induced E. coli cultures were incubated in a 37 °C 
shaking incubator set at 225 rpm for 5 h. This experiment was performed in 
duplicates. 
6. A TSA plate was prewarmed in a 37 °C incubator for 15 min. 
7. Soft agar in a bottle was melted in a microwave for 2 min. The bottle was 
cooled under running tap water while the agar was maintained in a liquid 
state. 2.7 ml of soft agar was further to a round bottom capped tube and 
held in a water bath set at 55 °C.  
8. 100 µl of In7 culture at OD600 ~0.2 was added to 2.4 ml of soft agar and 
uniformly mixed by vigorous shaking.  
9. 2.5 ml of In7 soft agar culture was transferred onto a prewarmed TSA plate 
and uniformly spread by tilting the plate. The plate was covered with lid and 
the agar overlay was allowed to solidify at room temperature for 1 h. During 
this process, the agar plate was left on a horizontal surface that was 
verified with a water leveller.   
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10.  10 µl of filtered supernatants from induced engineered E. coli and control 
E. coli cultures were spotted onto the In7 agar overlay and left to dry in a 
biological hood for 1 h.  
11. The plate was incubated in a 37 °C incubator for 6 h or more, and then 
analysed with ChemiDoc XRS bio-imager on epiwhite mode or with a high 
resolution digital camera. 
 
3.1.8 Live and Dead Fluorescent Microscopy 
This protocol describes a qualitative method to assess the effectiveness of 
engineered E. coli in killing P. aeruginosa. 
1. Overnight cultures of ln7 (P. aeruginosa) and QS-S5-E7 (E. coli Top10) 
were diluted in LB and harvested at an OD600 of 0.5 and 1.0 respectively. 
2. 3OC12HSL from ln 7 were obtained after passing ln7 culture through a filter 
membrane (0.22 μm) and the sterile filtrate was used to induce expression 
of engineered system by mixing it with QS-S5-E7 E. coli in 1:1 mixing ratio 
to a total volume of 2 ml. 
3. Resultant culture was grown for 3 hours and filtered with a similar 
membrane to obtain sterile S5 filtrate. 
4. The filtrate was mixed with ln7 at OD600 of 1.0 in 1:1 mixing ratio to a total 
volume of 2 ml and incubated for 3 hours. 
5. 1 ml of the final culture was stained with bacterial viability kit according to 
the manufacturer’s instruction and analysed with a fluorescent microscope. 
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3.1.9 Co-culture Inhibition Assay  
The co-culture inhibition assay discussed here provides a method to determine 
the ratio of engineered E. coli (EC) to P. aeruginosa (PA) cells that was 
required to completely inhibit the proliferation of P. aeruginosa. The protocol 
may be modified accordingly for the co-culture of other cell lines. 
1. Single colonies of P. aeruginosa isolate In7 (with plasmid pMC-PAGFP/CM) 
and engineered E. coli (QS-S5-E7) were inoculated into cell culture tubes 
each with 10 ml of LB plus ampicillin. The cell cultures were incubated in a 
37 °C shaking incubator set at 225 rpm for 15 h. 
2. Each culture was diluted to OD600 ~0.1 in 10 ml of LB plus ampicillin and 
grown to a final cell density of OD600  ~1.0 in the same conditions as 
described above.   
3. In7 and engineered E. coli cultures were mixed in round bottom capped 
tubes as described in Table 3-3 on ice (see Note 12). The mixed cultures 
were topped up to a total volume of 2 ml with LB plus ampicillin.  
4. The mixed cultures were incubated in a 37 °C shaking incubator set at 225 
rpm for 12 h. 
5. The Synergy HT Multi-Mode Microplate Reader was prepared for end-point 
measurement of fluorescence (485 nm excitation / 528 nm emission). 
6. At regular intervals of 3 h, 100 µl aliquots of the mixed cultures were 
transferred into a 96-well microplate for a total of two technical replicates. 
The 96-well microplate was then transferred to the microplate reader and 
analysed for background subtracted green fluorescence with pure LB plus 
ampicillin as the zeroing medium. 
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Table 3-3. Mixing ratio of P. aeruginosa and engineered E. coli in co-culture 
inhibition assay 
 
P. aeruginosa 
(ml) 
E. coli (ml) 
LB plus 
ampicillin (ml) 
EC/PA 
Ratio 
0.2 0 1.8 0 
0.2 0.2 1.6 1 
0.2 0.4 1.4 2 
0.2 0.6 1.2 3 
0.2 0.8 1 4 
 
 
7. Optional. The mixed cultures were serially diluted in the 96-well plate 10× 
with pure LB plus ampicillin. CFU count was then performed on a 
chloramphenicol selective LB agar plate. Only P. aeruginosa cells which 
carried the chloramphenicol resistance marker would develop into viable 
colonies.  
8. The mixed cultures were topped up with 200 µl of fresh LB plus ampicillin 
so that total volume of each co-culture was maintained at ~2.0 ml. The 
mixed cultures were incubated in the 37 °C shaking incubator with the 
same settings as described above. 
9. Normalised results were expored into MS Excel and a graph of relative 
green fluorescence (in RFU) was plotted against time (h). The optimal 
EC/PA ratio in preventing the growth of P. aeruginosa could be identified 
with a relatively constant GFP expression profile in the co-culture (see 
Note 13).  
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3.1.10 Biofilm Inhibition Assay 
This protocol provides a method to assess the effectiveness of engineered E. 
coli with Sense-Kill function (QS-S5-E7) in preventing the formation of 
Pseudomonas biofilm. The protocol may be modified accordingly for other co-
culture systems. 
1. Steps 1 – 2 of Section 3.2.8 were repeated with MHB ampicillin instead of 
LB.   
2. Engineered E. coli and P. aeruginosa isolate ln7/PAO1 from Step 1 were 
mixed in the ratio 4:1 with a total cell density of 1.0E-8 cfu/ml. The mixed 
cultured was gently mixed with a vortex. 
3. The co-culture mixture from Step 2 was transferred into a sterile 12-well 
microplate in 4 technical aliquots of 1 ml each. A transparent glass coupon 
was immersed at 45o into the well, allowing only half of the coupon to be in 
contact with the co-culture.  The microplate was sealed and incubated at 
37 oC at 150 rpm for 18 h.  
4. Glass coupons with intact biofilm were removed from the microplate with a 
tweezer. Planktonic cells were washed off by gently dipping the coupons in 
sterile water completely twice.  
5. Spent media in the 12-well microplate were disposed, leaving behind only 
biofilm cells (almost). Each well was further washed with 2 ml of sterile 
water twice to remove planktonic cells. The washing step was performed 
with extra care to minimise mechanical disruption to biofilm structures.  
6. Each well was filled with 1 ml of fresh MHB chloramphenicol. Biofilm cells 
were recovered in the fresh media by sonication or vigorous pipetting. 
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7. Biofilm cells form in each well were quantified by counting the number of 
viable cells on LB agar plates with chloramphenicol. The effectiveness of 
biofilm inhibition was determined using Eqn. 3.6,  
% Biofilm Survival =   
CFU of 𝑃.𝑎𝑒𝑟𝑢𝑔𝑖𝑛𝑜𝑠𝑎 biofilm in treated sample  ×100
CFU of 𝑃.𝑎𝑒𝑟𝑢𝑔𝑖𝑛𝑜𝑠𝑎 biofilm treated with WT 𝐸.𝑐𝑜𝑙𝑖  
                                    𝐄𝐪𝐧. (𝟑. 𝟔)    
                                   
8. Biofilm structures on the glass slides from Step 4 could be visually 
inspected using a confocal microscope with GFP detection channel. 
 
3.2 Engineering Digital Logic Operations in Microbe 
3.2.1 Design of AND, OR, NOT, XOR and Half Adder Genetic Circuits  
To equip commensal microbes with the ability to “think” and “process” logical 
decisions, the cells could be rewired to exhibit half adder digital operations, 
which is the basic unit of microprocessor chips in electronics. Figure 3-3 
shows the design of the biological half adder in a single E. coli cell.  The half 
adder consisted of 3 independent biologically-derived AND, OR and NOT logic 
gate - a fourth AND logic function that was not a physical device, but a result 
of programmable decision making as a result of interconnecting logic functions.  
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AraC and RhaS, both of which were constitutively expressed in a single 
transcript by promoter pCon, would associate with their corresponding 
inducers to activate expression of the enhancer-binding proteins HrpS and 
HrpR. This resulted in the activation of the AND logic and the concurrent 
synthesis of GFP reporter and lambda repressor (λCl) by the pHrpL promoter. 
Consequently, genetic events of the OR gate, which ran in parallel with the 
HrpRS AND gate, would be turned off due to obstructive repression by λCl 
molecules. In all, the half adder demonstrated both AND (SUM Output) and 
XOR (CARRY Output) logic operations, the latter operation was a processed 
outcome achieved by sequential and parallel layering of AND, OR and NOT 
logic (Figure 3-4A). By comparison, induction with either inducer singly would 
trigger only genetic operation of the OR gate, resulting in the synthesis of RFP 
reporter, but not GFP and λCl molecules (Figure 3-4B). 
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3.2.2 Biobrick Assembly 
The biobrick assembly method can be used to construct synthetic genetic 
circuits using standardised biobrick vectors which possessed EcoRI, XbaI, 
SpeI and PstI restriction sites. This method allows the same restriction sites to 
be repeatedly used even when the engineered system gets progressively 
larger. 
1. For the front insertion, 500 ng of PCR amplified insert and 300ng of 
biobrick vector were digested with EcoRI-HF / SpeI, and EcoRI-HF / XbaI 
for 5 h at 37 oC, respectively. For back insertion, 500 ng of PCR amplified 
insert and 300ng of biobrick vector were digested with XbaI / PstI, and SpeI 
/ PstI for 5 h at 37 oC, respectively. In both cases, total reaction volume 
was adjusted to 25 µl (Table 3-4).  
2. Alternatively, to transfer PCR amplified insert into an empty biobrick vector 
without upstream or downstream constructs, 500 ng of insert and 300 ng of 
vector were independently digested with XbaI / PstI for 5 h at 37 oC.  
3. Digested insert and vector fragments were purified with Minelute PCR 
purification columns according to the manufacturer’s instructions. 
 
Table 3-4. Digestion reaction composition 
 
Initial Concentration Volume per 25 µl reaction 
Sterile ddH2O up to 25 µl 
NEB Buffer 2.1 (10×) 2.5 µl 
Restriction Enzyme 1 1 µl 
Restriction Enzyme 2 1 µl 
DNA (300 ng Vector / 500 ng Insert) variable 
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4. The amount of purified DNA was measured using Nanodrop.  
5. 100 ng of purified vector was dephosphorylated with 1 µl rAPid alkaline 
phosphatase in a total reaction volume of 10 µl using the thermocycler 
settings as shown in Table 3-5.  
6. T4 DNA ligase buffer was thawed on ice. Sterile water, digested purified 
and insert, and dephosphorylated vector were also held on ice until use.  
7. 20-50 ng of phosphorylated vector was ligated with up to 70 ng of purified 
insert using 1 µl of T4 DNA ligase in a total reaction volume not exceeding 
20 µl. The mixture was gently mixed by pipetting up and down and 
incubated overnight at 10 oC. 
8. 10 µl of ligation mixture was then transformed into competent E. coli cells 
and successful construct was screened by colony PCR.  
 
Table 3-5. Dephosphorylation cycling conditions 
 
Cycle No. Temperature Function 
1 37 °C, 60 min Dephosphorylation 
2  75 °C, 5 min Denaturation 
3 4 °C, ∞ Cooling 
 
 
3.2.3 Characterisation and Orthogonal Testing of Input Switches 
1. A single colony of E. coli expressing relevant input switch construct was 
inoculated into 5 ml of LB medium with appropriate antibiotic. The culture 
was incubated in a 37 °C shaking incubator set at 225 rpm for 15 h. 
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2. After 15 h of incubation, the culture was diluted 100× in 10ml of prewarmed 
LB antibiotic medium and grown to an OD600 of 0.5 under the same 
conditions. This corresponded to mid-log phase of the cells. 
3. 100× stock solution of arabinose and rhamnose inducer 2.8 M were diluted 
in serial 2-fold dilution with sterile water to obtain 16 different 
concentrations of inducers ranging from 10-6 – 2.8 M. 
4. While waiting for the re-inoculated cultures to grow to the desired cell 
density, 1.5 µl of each inducer concentration was added to the microplate 
in triplicates.  
5. 150 µl of re-inoculated culture was then transferred into each well with 
inducers to activate gene expression. The cultures were incubated at 37 oC 
for 3 h in the microplate shaking incubator with 750 rpm shaking. 
6. The cultures were analysed for background subtracted absorbance and 
RFP fluorescence using a microplate reader with excitation and emission 
wavelength of 590 nm and 640 nm respectively. The data were then to MS 
Excel. RFP fluorescence was normalised with cell density estimated from 
A600 to obtain RFP/cell in arbitrary units. 
7. Experimental results were fitted to an empirical mathematical model as 
shown in Eqn. 3.7 using Matlab Curve Fitting Toolbox where A, B, C and n 
are curve-fitted empirical parameters. 
            Output Y, RFP = A + 
B(Xn)
Cn + Xn
                                                𝐄𝐪𝐧. (3.7) 
8. The experimental data and empirical transfer function of each input switch 
device were plotted on the same graph with MS Excel.  
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3. 150 µl of re-inoculated culture was transferred into each well with inducers 
to activate gene expression. The cultures were then incubated at 37 oC for 
3 h in the microplate shaking incubator with 750rpm shaking. 
4. Background subtracted GFP (480 nm / 530 nm) or RFP (590 nm / 640 nm) 
fluorescence and A600 absorbance were measured using microplate reader 
with suitable excitation and emission wavelength. The fluorescent values 
obtained were normalised with A600 estimated cell density to obtain 
fluorescence output per cell in arbitrary units. 
5. Experimental results were plotted on a 3D surface plot with Input A 
(arabinose), Input B (rhamnose) and fluorescence output as X-Y-Z axis 
respectively using Matlab plotting tools.  
 
3.2.5 Parts Mutagenesis of λCl repressor Binding Sites 
1. PCR library fragments of pBADCl2-RFP were generated using pBADCl2A-
RFP as the template, and forward and reverse primers as listed in 
Appendix A. The PCR products were then ligated downstream of pHrpL-
λCl (pSB1C3, CmR) as described in Section 3.2.2. 
2. The library of genetic circuits were then chemically transformed into E. coli 
cells with AND gate construct. 
3. 24 single colonies of the transformed cells were picked with sterile 
toothpicks into 96-well plate prefilled with 200 µl of growth LBAC media. 
The microplate was then sealed with air-permeable foil. 
4. The microplate culture was incubated at 37 oC with 750 rpm shaking in a 
microplate incubator with heated lid for 6 h. 
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estimated cell density to obtain fluorescence output per cell in arbitrary 
units. 
5. The normalised outputs of half adder and half subtractor were plotted on 
MS Excel. In the case of XOR gate, the results were analysed on a 3D 
surface plot with Matlab as described in Step 5 of Section 3.2.3.  
 
3.2.7 Flow Cytometry of Half Adder and Half Subtractor 
1. Steps 1 – 3 of Section 3.2.6 were repeated with E. coli carrying “Half 
Adder” or “Half Subtractor” constructs.  
2. The culture tubes were then transferred to a 4 oC fridge and chilled for 15 h 
to allow GFP and RFP molecules to completely mature and stabilize.  
3. 5 µl of each culture was subsequently diluted in 1.5 ml of filtered DI water 
in separate flow cytometry tubes and mixed by vortexing (Note 14). 
4. BD LSRFortessa X-20 flow cytometer was set up according to the 
manufacturer’s instruction. E. coli cells were then gated using both forward 
(550 v, threshold 1500 v) and side scatter (310 v) with the neutral density 
filter removed (Note 15). FITC (530 nm ±30) and PE594 (610 nm ±20) 
were set to 466 v and 852 v respectively.  
5. At least 10,000 events were recorded. Data was analysed using the 
histogram overlay feature of Flowjo.  
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3.3 Statistical Analysis 
In all figures presented in this thesis, error bars represent the standard 
deviation of the mean of n independent experiments or biological replicates, 
where n ≥ 2. The mean, ӯ and standard deviation, σ were determined using 
Eqn. 3.8 and 3.9, respectively.  
 
            Statistical Mean, ӯ =
∑ y𝑖
𝑖=𝑛
1  
𝑛
                                               𝐄𝐪𝐧. (3.8) 
            Standard Deviation, σ = √
1 
𝑛
∑(𝑦𝑖 −  ӯ)2
𝑖=𝑛
1
                      𝐄𝐪𝐧. (3.9) 
 
3.4 Notes 
1. pMC-PAGFP/CM carried both chloramphenicol and carbenicillin selection 
marker and drove constitutive expression of GFP in P. aeruginosa with a 
Lac promoter. It allowed for quantification of P. aeruginosa viability by both 
fluorescence measurement and CFU count and could be used to image 
Pseudomonas biofilm by confocal fluorescence microscopy. 
2. Inserts below 300 bp are recommended to be spliced together into longer 
fragments by overlap extension PCR. Splicing overlap extension (SOE) 
could be performed with equimolar ratio of DNA fragments, setting the 
largest fragment as the basis of comparison (100 ng). Of note, the primers 
designed for SOE PCR should have at least 20 – 25 bp of overlapping 
sequences, and designed without secondary structures that may otherwise 
interfere with DNA recombination. 
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3. Primer design is a balance between economics and having sufficient 
overlapping sequence such that the Tm is greater than 50 °C. Most gene 
synthesis companies offer standard desalted primers at affordable rates for 
oligos of up to 50 bp. 
4. Spacer sequences were incorporated when repeated gene sequences 
were present in the construct, such as the repetitive use of similar 
promoters and terminators. Essentially, spacer sequences should be 
designed with ~50% GC content and distinctly different from other spacer 
sequences to prevent cross interference. Also, it is imperative that the 
spacer sequences (1) do not form hairpin structure in the 5'UTR or 
introduce unwanted transcription and translation termination (TAA, TGA & 
TAG), (2) are free from possible Shine-Dalgarno sequences, start codons 
(ATG, GTG & TTG) and methylation sites (GATC) of E. coli, (3) are free 
from unwanted restriction sites.  
5. The concentration of amplified DNA recovered with QIAquick Gel 
Extraction Kit could be enhanced by recovering the two 40 µl volumes of 
PCR reaction in a single column. The final elution volume with nuclease-
free water could be reduced to 20 µl instead of 30 µl as stated by the kit’s 
instructional manual. Alternatively, 30 µl of eluted DNA were concentrated 
with a vacuum evaporator. Higher yield of DNA could be recovered during 
elution step by leaving the spin columns to stand in a 55 °C heat block for 2 
min after nuclease-free water is added before collection. 
6. In the previous work using pTet-LasR-pLux-GFP as the reporting device, 
we observed relatively uniform GFP production rate between 20 – 80 min 
after AHL induction144. Note that the period in which steady state GFP 
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production rate was observed could vary in disparate designs of quorum 
sensing devices. Thus, characterisation on a case-by-case basis may be 
necessary. 
7. This additional dilution step reduced the amount of aging cells with 
unhealthy surface morphology and enhances surface contrast between 
lysed and unlysed cells. 
8. The precise volumes to resuspend the cell pellets depend on the amount of 
cells and some trial and error optimisation may be necessary. Generally 
after 2 h of induction, we observed that the engineered E. coli with lysis 
device could be resuspended in 10 µl while the control E. coli with much 
more viable cells could be resuspended in 40 µl for good comparison.  
9. While primary fixation with glutaraldehyde serves to cross-linked proteins, 
secondary fixation with osmium tetraoxide enables the fixation of lipids and 
is recommended for surface morphology studies. Note that osmium 
tetraoxide is rapidly converted to osmium dioxide which is no longer able to 
fix cells on exposure to heat or light. 
10. Prolonged dehydration may lead to cell shrinkage, especially at low ethanol 
concentration. 
11. A secondary dehydration step with acetone/HMDS (hexamethyl disilazane) 
solvent could be performed to improve contrast by serial immersion of the 
loaded silicon slides in 2:1 acetone:HMDS, 1:2 acetone:HMDS and 100% 
HMDS (see Ref.154) . 
12. Here, we have established that an OD600 ~1.0 corresponds to 1.0E8 cfu/ml 
of E. coli cells with a spectrophotometer. Due to optical variability in 
different spectrophotometers, we advised that OD600-CFU calibration 
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curves be generated to determine the actual cell densities before mixing 
different cell cultures together. 
13. GFP molecules are stable for more than 24 h and therefore a constant 
level of GFP fluorescence still exist for growth-inhibited P. aeruginosa cells. 
Alternatively, a less stable variant of GFP reporter with shortened half-life 
may be used to assess the number of viable directly cells by flow 
cytometry. 
14. In this experiment, 3 pulses of 3 s on vortex set at medium intensity was 
sufficient for good mixing and prevented bacteria from clogging up as a 
single particle. 
15. Removing the neutral density filter allowed the flow cytometer to detect 
bacterial cells with greater sensitivity. Care should be noted to avoid gating 
at high voltage as background noise was also amplified. 
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Chapter Four 
4. ENGINEERING COMMENSAL MICROBE TO SENSE AND ERADICATE 
PSEUDOMONAS AERUGINOSA 
Communications between P. aeruginosa cells are mediated by diffusible 
chemical signals through a process known as quorum sensing.  Quorum 
sensing is a cell density dependent property; the synthesis of homoserine 
lactones are regulated by a positive feedback mechanism that is proportional 
to the population density of the pathogen85. In synthetic biology, genes that 
encode for biological functions are considered as fundamental building blocks 
for engineering biology. That is, by transferring the genes encoding for quorum 
sensing function from Pseudomonas into target chassis, the engineered 
microbe could also be functionalised with the ability to sense Pseudomonas 
pathogen. In this chapter, the development of a synthetic genetic system, 
which comprises quorum sensing, killing, and lysing devices, that enabled 
Escherichia coli to sense and kill a pathogenic Pseudomonas aeruginosa 
strain through the production and release of pyocin is discussed. The sensing, 
killing, and lysing devices were characterised to elucidate their detection, 
antimicrobial and pyocin release functionalities, which subsequently aided in 
the construction of the final system and the verification of its designed 
behavior. Constructs developed in this chapter are shown in Figure 4-1. The 
work was published in Molecular Systems Biology, EMBO Press144. 
Saeidi Nazanin, Choon Kit Wong* et al. Engineering microbes to sense and eradicate 
Pseudomonas aeruginosa, a human pathogen. Mol Syst Biol 7 (2011). 
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Figure 4-1: Plasmid map of engineered system and devices. (A) The final engineered system, control constructs include: (B) Sensing device 
coupled to GFP, (C) sensing device with E7 lysis, and (D) sensing device with pyocin S5. The figure is reproduced from 144  with permission. 
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4.1 Characterisation of Quorum Sensing Device 
To evaluate and characterise the sensing device, the gene encoding the green 
fluorescent protein (GFP) was fused to the sensing device (i.e. pTetR-LasR-
pLuxR-GFP; the plasmid map is shown in Figure 4-1B) and GFP expressions 
were monitored over a range of concentrations of 3OC12HSL. GFP content in 
bacterial culture and cell density were quantified in terms of the relative 
fluorescence unit (RFU) and optical density (OD). Assuming a linear 
dependence of GFP concentration with RFU and cell density with OD, the 
quotient RFU/OD provided a reasonable quantification of the amount of GFP 
per cell. Further, the rate of GFP synthesis per cell could be estimated by 
taking the ratio of Δ(RFU/OD) over a small time interval Δt. From the 
measured GFP synthesis rates (Figure 4-2), we observed a basal expression 
level of 0.1 RFU OD-1min-1 without induction, followed by a sharp increase in 
GFP production rate as the concentration of 3OC12HSL were increased 
beyond 1.0E-7 M. This transition peaked at 1.0E-6 M of 3OC12HSL and 
exhibited a sharp decline afterward. These results suggest that the optimal 
detection range of the sensing device was between 1.0E-7 M and 1.0E-6M 
3OC12HSL. At 3OC12HSL concentration above 1.0E-6 M, diffusion of quorum 
signals into cell was not rate-limiting, leading to rapid gene expression within 
the first 20 min. Significant metabolic burden was exerted on the cell and this 
resulted in inadvertent failure of the sensing device after about 60 min.  
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Figure 4-2: Characterisation of quorum sensing device with GFP reporter. GFP production rate is reported over a range of autoinducer (3OC12HSL) 
concentration and time. The figure is reproduced from 144  with permission. 
Time (mins)
[3O-C12HSL]
GFP Production Rate
(RFU OD-1 min-1)
[3O-C12HSL]
Time (mins)
79 
 
 
 
A goal of synthetic biology is to ensure that the compositional property of an 
engineered device is preserved when used jointly with other biological parts. 
However, complex biochemical kinetics usually prevents a thorough 
understanding of novel devices and hinders any efforts in process optimisation.  
Herein, quorum sensing dynamics of the sensing device was accurately 
described by fitting an empirical mathematical model (Hill equation) to the 
experimental data where the input 3OC12HSL concentration was smaller than 
1.0E-6 M. The performance of quorum sensing receiver was modelled by 
determining the average GFP synthesis rate under two conditions: (1) at 
inducer concentration below 1.0E-6 M 3OC12HSL and (2) at time between 20 
to 100 minutes after induction when GFP synthesis rate was assumed to be at 
pseudo steady state with fairly constant expression throughout for a particular 
inducer concentration. Nonlinear curve fitting of the experimental results into a 
transfer function model was implemented with Matlab Curve Fitting toolbox to 
derive the characteristic hill coefficient and constant.   The resulting best fit 
model demonstrated that the static performance of the sensing device follows 
a Hill equation below the input concentration of 1.0E-6 M 3OC12HSL (Figure 
4-3).
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aeruginosa infection as described in the previously literature146, 147, the sensing 
device would be responsive to detect the amount of 3OC12HSL natively 
produced by P. aeruginosa.  
 
4.2 Estimation of Native Autoinducer Produced by P. aeruginosa 
As stated above, the characterisation of the sensing device indicated that it 
produced an optimal output at 1.0E-7 M to 1.0E-6 M 3OC12HSL. To verify that 
the sensing device would be able to sense the amount of 3OC12HSL natively 
produced by P. aeruginosa, the sensing device coupled with a GFP reporter 
(i.e. pTetR-LasR-pLuxR-GFP) was induced using filtered cultures of different P. 
aeruginosa clinical isolates. Filtered supernatant of the Pseudomonas isolates 
were mixed with E. coli carrying the sensing device with GFP reporter at ratios 
of 1:100 and 1:10.  This was necessary as the earlier characterisation results 
with synthetic 3OC12HSL implied that a certain GFP production rate per cell 
could correspond to inducer concentration either below or above 1.0E-6 M. To 
estimate the concentration of 3OC12HSL produced by various P. aeruginosa 
isolates, time-averaged GFP production rates (Figure 4-4) due to induction by 
AHL from P. aeruginosa were substituted in the transfer function model. 
Figure 4-5 shows the estimated concentration of exogenous 3OC12HSL 
produced and released by P. aeruginosa clinical isolates. The average 
concentration of 3OC12HSL in liquid cultures of the P. aeruginosa strains were 
estimated to be approximately 1.0E-6 M 3OC12HSL. This result was coherent 
with previous studies that had estimated that the extracellular concentration of 
3OC12HSL was between 1.0E-6 and 1.0E-4 M 146, 147. Results from this 
experiment also suggests that certain strains of P. aeruginosa such as ln4 may 
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not synthesize autoinducer under the same conditions as other strains due to 
slight variation in regulatory pathway. ln7 was identified as the strain with the 
highest secretion of type I autoinducer and would be further tested for co-
culturing with engineered treatment system. 
 
 
Figure 4-4: GFP production rate of different P. aeruginosa isolates. Time-averaged GFP 
production rate between 20 ~ 80 minute after induction with 1:100 and 1:10 filtered 
supernatant. Error bars represent the standard deviation of three biological replicates. 
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Figure 4-5: Concentration of 3OC12HSL autoinducer secreted by different P. aeruginosa 
clinical isolates. The average concentration of 3OC12HSL in liquid cultures of P. aeruginosa 
was estimated to be 1.0E-6 M. The figure is reproduced from 144  with permission. 
 
4.3 Characterisation of Lysis Device 
In the conceptual design of the engineered commensal bacteria, E7 lysis 
device was introduced to mediate the release of accumulated S5 pyocins on 
quorum sensing detection of extracellular 3OC12HSl released by P. aeruginosa. 
Henceforth, to characterise the activity of the lysis device, the E7 lysis gene 
was ligated downstream to the sensing device (i.e. pTetR-LasR-pLuxR-E7; the 
plasmid map is shown in Figure 4-1C) and its performance was assessed in 
an E. coli chassis by measuring absorbance at OD600 over a range of 
concentrations of 3OC12HSL and time. Figure 4-6A shows that at 0 and 1.0E-
8 M 3OC12HSL, the growth rates of E. coli underwent no noticeable transition 
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into a lysis state. However, at higher concentrations of 3OC12HSL (i.e., 1.0E-
6M and 1.0E-4 M), the cells exhibited a significant reduction in optical density, 
likely due to the lysis activity.  
 
The results imply that 1.0E-6M or higher concentrations of 3OC12HSL cause 
observable cell lysis with a delay of approximately 120 minutes. To verify the 
effect of the lysis, cell integrity was examined with and without 1.0E-6M 
3OC12HSL using Field Emission Scanning Electron Microscopy (FESEM). 
Figure 4-6B illustrates that E. coli containing pTetR-LasR-pLuxR-E7 and 
induced with 3OC12HSL appeared shrivelled with corrugated surface 
morphology as opposed to the distinct ‘rod-like’ features of healthy E. coli cells 
that were not induced with 3OC12HSL. The result suggests that lysed cells 
tend to implode from its initial shrivelled state, possibly due to the release of 
cellular content as similar to air escaping from a balloon. Under the collapsed 
state, light from spectrophotometer would less likely be absorbed by opaque 
cellular material, resulting in lower absorbance measurements. To further 
confirm that the lysis activity can be sustained in the final system including 
pyocin S5, the morphology of E. coli containing the final system (i.e. pTetR-
LasR-pLuxR-S5-pLuxR-E7; the plasmid map is shown in Figure 9A) were 
monitored using FESEM. 
 
Figure 4-6C shows that E. coli cells having the final system and induced with 
3OC12HSL also appeared shrivelled with corrugated surface morphology, 
while E. coli cells having the final system (without induction) remained ‘rod-like’ 
in shape. These observations were comparable to those obtained in the earlier 
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experiment with E. coli containing only the lysis device (i.e. pTetR-LasR-
pLuxR-E7) and suggestively implied the engineered E. coli containing the final 
system were able to lysed themselves on sensing exogenous 3OC12HSL.  
 
In line with the overall objective of the E7 lysis device in mediating the export 
of pyocin, we assessed the efficiency of the lysis device in the final system by 
measuring the amount of the pyocin released. Histidine-tagged S5 protein was 
purified by immobilized metal affinity chromatography from the filtered 
supernatant and analysed by SDS PAGE (Figure 4-7A) and Bradford assay 
after induction with 1.0E-6 M 3OC12HSL (Figure 4-7B). Whereas no bands 
were seen on the SDS PAGE of an incomplete system without the lysis device 
(i.e. pTetR-LasR-pLuxR-S5; the plasmid map is shown in Figure 4-1D), 
distinct bands that are indicative of pyocin S5 were observed on the SDS 
PAGE of the final system (i.e. pTetR-LasR-pLuxR-S5-pLuxR-E7).   
 
Additionally, we validated the results by estimating the protein concentrations 
in the supernatant with Bradford assay and showed that the amount of pyocin 
released by the final system was eight fold higher than a system without the 
lysis device. Activity of the lysis device in the final system was characterised 
by an impulse release of protein two hours after induction, which was 
eventually succeeded by a steady discharge of pyocin S5.  
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4.4 Overlay Inhibition Assay with AHL and the Final System 
Thus far, commensal E. coli were engineered to sense 3OC12HSL signals and 
lysed itself to mediate the export of intracellular proteins such as pyocin S5. To 
study whether the sensing of 3OC12HSL also triggers the killing of P. 
aeruginosa as designed, the growth of P. aeruginosa were monitored in the 
presence of the engineered E. coli containing the final system.  
 
To determine if the concentration of AHL required to elicit the expression and 
production of P. aeruginosa bacteriocidal peptides were within the range of 
concentrations of 3OC12HSL naturally produced by the pathogen, the 
engineered E. coli were induced with synthetic 3OC12HSL at 0, 1.0E-8 M, 
1.0E-6 M, and 1.0E-4 M, after which their filtered supernatants were spotted 
onto P. aeruginosa-grown agars. Clearly, the growth of P. aeruginosa were 
suppressed by filtered supernatants of the E. coli cultures exposed to 1.0E-6M 
and 1.0E-4 M 3OC12HSL, as distinguished by the halo clearings in the overlay 
inhibition assay, in contrast to very pale inhibition zones from possible basal 
expression of pyocin S5 and E7 lysis proteins observed at 0 and 1.0E-8 M  
3OC12HSL (Figure 4-8A).  
 
Consequently, to confirm the killing activity by the native 3OC12HSL produced 
by P. aeruginosa, the filtered supernatant of P. aeruginosa cultures were 
mixed with the E. coli cultures, whose supernatants were then added to P. 
aeruginosa-grown agars. Figure 4-8B shows that P. aeruginosa growth were 
significantly suppressed by the engineered E. coli cultures exposed to the 
supernatant of P. aeruginosa cultures, while neither the wild-type E. coli cells 
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with nor without the P. aeruginosa supernatant led to growth inhibition. This 
result indicates that the final system produces pyocin S5 and E7 lysis proteins 
on sensing native 3OC12HSL from P. aeruginosa, subsequently leading to the 
killing of the pathogen.  
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 ,QKLELWLRQ DVVD\ RI 3 DHUXJLQRVD DIWHU H[SRVXUH WR VXSHUQDWDQW RI  GLIIHUHQW
FXOWXUHV )LUVW 3 DHUXJLQRVD H[SRVHG WR VXSHUQDWDQW RI ZLOGW\SH ( FROL VKRZHG QR
EDFWHULFLGDODFWLYLW\6HFRQG3DHUXJLQRVDH[SRVHGWRVXSHUQDWDQWRIZLOGW\SH(FROLPL[HG
ZLWK3 DHUXJLQRVD SURGXFHG QR LQKLELWLRQ ]RQHV 7KLUG H[SRVXUH WR VXSHUQDWDQW RI ( FROL
FDUU\LQJ ILQDO V\VWHP GLG QRW SURGXFH DQ\ LQKLELWLRQ DV ZHOO )RXUWK RQO\ 3 DHUXJLQRVD
H[SRVHG WR VXSHUQDWDQW RI ( FROL FDUU\LQJ ILQDO V\VWHP ZLWK 3 DHUXJLQRVD GLVSOD\HG FOHDU
LQKLELWLRQ ]RQHV ZKLFK VXJJHVWHG WKDW WKH V\VWHP SURGXFHG VXIILFLHQW S\RFLQ 6 WR H[KLELW
EDFWHULFLGDODFWLYLW\7KHILJXUHLVUHSURGXFHGIURPZLWKSHUPLVVLRQ
91 
 


/LYHDQG'HDG)OXRUHVFHQW0LFURVFRS\ZLWK)LQDO6\VWHP

)LJXUH 3 DHUXJLQRVD FHOOV VWDLQHG XVLQJ WKH /,9('($' FHOO YLDELOLW\ DVVD\0DQ\ 3
DHUXJLQRVD FHOOV ZHUH VWDLQHG ZLWK 3, G\H ZKLFK LQGLFDWH GHDG FHOOV ZKHQ H[SRVHG WR
VXSHUQDWDQW RI HQJLQHHUHG ( FROL FDUU\LQJ WKH ILQDO V\VWHP WKDW ZDV LQGXFHG E\ QDWLYH
2&+6/ SURGXFHG E\3 DHUXJLQRVD 6FDOH EDU  ȝP7KH ILJXUH LV UHSURGXFHG IURP 
ZLWKSHUPLVVLRQ

7RYLVXDOLVH WKHH[WHQWRI LQKLELWLRQE\ WKHHQJLQHHUHG( FROL3DHUXJLQRVD
ZHUH H[DPLQHG DIWHU H[SRVXUH WR WKH VXSHUQDWDQW RI WKH ( FROL FXOWXUHV
LQGXFHGZLWKQDWLYH2&+6/IURP3DHUXJLQRVDXVLQJ WKH/,9('($'FHOO
YLDELOLW\DVVD\5HVXOWVIURPIOXRUHVFHQWPLFURVFRS\VKRZVWKDW3DHUXJLQRVD
FHOOV WKDW ZHUH H[SRVHG WR WKH VXSHUQDWDQW RI WKH HQJLQHHUHG ( FROL ZHUH
VWDLQHGZLWKWKHUHG3,G\HZKLFKVWDLQVDGHDGFHOOZKHUHDVWKRVHWKDWZHUH
LQFXEDWHGZLWKWKHZLOGW\SH(FROLZHUHPRVWO\VWDLQHGZLWKWKHJUHHQ6<72
G\H ZKLFK VWDLQV D OLYH FHOO )LJXUH  7KLV UHVXOW VXJJHVWV WKDW WKH
HQJLQHHUHG(FROLFDUU\LQJWKHILQDOV\VWHPFDQNLOO3DHUXJLQRVDLQUHVSRQVH
WR2&+6/QDWLYHO\SURGXFHGE\3DHUXJLQRVD
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WR LQKLELW3 DHUXJLQRVD LQ DPL[HG FXOWXUH WKH JURZWK RI3 DHUXJLQRVD FR
FXOWXUHGZLWKWKHHQJLQHHUHG(FROLLQWKHUDWLRZDVHYDOXDWHG6LQFHERWK
VWUDLQVRIEDFWHULDGLVSOD\URGOLNHPRUSKRORJ\3DHUXJLQRVDZDVWUDQVIRUPHG
ZLWKS053WRGLIIHUHQWLDWHWKHSDWKRJHQIURP(FROLE\JUHHQIOXRUHVFHQFH
)LJXUH  VKRZV QRUPDO OLJKW DQG IOXRUHVFHQW PLFURVFRS\ LPDJHV RI 3
DHUXJLQRVD FOLQLFDO LVRODWH OQ WKDW ZHUH WUDQVIRUPHG ZLWK $ DQG & DQG
ZLWKRXW *)3 UHSRUWHU % DQG '  )XUWKHU WR GHPRQVWUDWH WKDW RQO\ WKH
HQJLQHHUHG(FROLHTXLSSHGZLWKDOO WKUHHELRORJLFDOGHYLFH±VHQVLQJ O\VLQJ
1μm
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and killing, were able to suppress the pathogen, E. coli systems without either 
the pyocin S5 or E7 lysis devices were used as negative controls in this study.  
 
Figure 4-11 shows that the GFP expression level of the P. aeruginosa co-
cultured with the E. coli that carried the final system remained low and almost 
constant, whereas the GFP level of P. aeruginosa that was cultured together 
with the negative control E. coli systems increased continuously. To verify the 
efficiency in growth inhibition, I also performed CFU count on mixed cultures 
using P. aeruginosa that was transformed with chloramphenicol resistant 
plasmid. Figure 4-12A shows that the engineered E. coli effectively inhibited 
the growth of P. aeruginosa when the pathogen produced sufficient 
autoinducer molecules in the late exponential and early stationary phase. The 
results also implied that only the engineered E. coli, were able to suppress P. 
aeruginosa by 99% while growth of the pathogen persisted when treated with 
incomplete E. coli systems without either killing or lysis devices (Figure 4-
12B).  
 
94 
 



)LJXUH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RIUHSOLFDWHV7KHILJXUHLVUHSURGXFHGIURPZLWKSHUPLVVLRQ


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Figure 4-12: (A) Cell viability and (B) Percentage survival of P. aeruginosa in mixed culture with the engineered E. coli. Pseudomonas in the mixed culture 
was quantified by viable cell count using chloramphenicol selection. The result shows that the engineered E. coli suppressed the growth of P. aeruginosa by 
99%. In contrast, inhibition was less observed in P. aeruginosa co-cultured with incomplete E. coli systems without either the killing device or lysis device. 
Error bars represent the standard deviation of 3 replicates. The figure is reproduced from 144  with permission. 
A B 
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ZLWKWKHHQJLQHHUHG(FROLFDUU\LQJWKHILQDOV\VWHPDVFRPSDUHGWR
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VWDQGDUGGHYLDWLRQRIUHSOLFDWHV7KHILJXUHLVUHSURGXFHGIURPZLWKSHUPLVVLRQ
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Figure 4-14 shows that the morphology of Pseudomonas biofilm treated with 
the engineered E. coli appeared thinner and sparser while elaborated water 
channels and honey-combed features were seen in the control experiments. 
This observation implies that the engineered E. coli was able to inhibit biofilm 
formation during the initial attachment phase and prevented subsequent 
progression into mature micro-colonies. Despite the preliminary success, it is 
apparent that further extensive experimental studies in direct disease-relevant 
models are necessary. In particular, future studies should examine the in vivo 
efficacy of the engineered E. coli in controlling the growth of P. aeruginosa in 
infected murine models. 
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4.8 Conclusion 
One of the major health concerns of today is the emergence of superbug 
infections that cannot be controlled with antibiotics. Probiotics are commensal 
bacteria that promote human health benefits and have been used for 
prophylactic and therapeutic control of microbial infections. Despite the 
effectiveness of probiotics, their applications are confined to a narrow 
spectrum of infection types. Drawing inspiration from nature, we developed a 
prototype of designer probiotic to combat superbug infection by reprograming 
human commensal E. coli with genetic devices that enabled E. coli to sense 
biomarkers from microbial pathogen and produce corresponding killing 
molecules to eradicate the pathogen. The sensing, killing, and lysing devices 
were characterised to elucidate their functionalities, which subsequently aided 
in the construction of the final system and the verification of its designed 
behavior. Based on the characterisation and modeling results, we verified that 
the sensing device had an optimal activity approximately in the range of 1.0E-7 
to 1.0E-6 M 3OC12HSL, which was in line with the concentration of 3OC12HSL 
secreted by P. aeruginosa. We further confirmed the activities of the killing and 
lysing devices in response to this range of 3OC12HSL concentration. Finally, 
we demonstrated that the engineered E. coli with the complete system 
effectively killed P. aeruginosa in both planktonic and biofilm states when 
those two microbes were grown together. The synthetic biology framework and 
genetic devices developed in this work could potentially be transferred into 
other microbial chassis such as probiotics and residential microbes of the 
upper respiratory tract39, 155. Further, this study presents the possibility of 
engineering potentially beneficial microbiota into therapeutic bioagents to 
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arrest Pseudomonas infection. Given the stalled development of new 
antibiotics and the increasing emergence of multi-drug-resistant pathogens, 
this study provides the foundational basis for a novel synthetic biology-driven 
antimicrobial strategy that could be extended to include other pathogens such 
as Vibrio cholera and Helicobacter pylori.    
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Chapter Five 
5. ENHANCING WHOLE CELL BIOSENSORS WITH AND & OR LOGIC 
OPERATIONS 
In the previous chapter, a commensal microbe with sensing, lysing and killing 
functions was developed to mitigate the proliferation of the Pseudomonas 
superbug in vitro. While quorum sensing with N-3-oxododecanoyl homoserine 
lactone is by and large, a successful method to detect a growing population of 
Pseudomonas, there are reports that quorum regulatory mechanisms are 
quiescent in certain virulent isolates of P. aeruginosa, possibly to enhance 
survival under more stressful environmental conditions or to evade immune 
arrest 156, 157. The recent discovery that a second class of quorum sensing 
mechanism mediated by 4-hydroxy-2-alkylquinolines, exists in P. aeruginosa 
may be an additional tool to identify the pathogen 158. Alternatively, direct 
sensing of virulent determinants such as exotoxins may provide a more 
responsive and expansive detection. Despite the many biomarkers that are 
available for whole cell biosensing, an apparent shortage of genetic interface 
that could integrate and compute multiple input signals into the desired outputs 
has hindered the development of whole-cell biosensors with better specificity 
and sensitivity. In this chapter, a novel forward engineering approach to enable 
digital operations in synthetic biological systems will be discussed. In particular, 
an orthogonal set of AND and OR logic gates were developed and rigorously 
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characterised using a bottom-up synthetic biology approach. The design 
principles and scientific findings documented from this chapter will be valuable 
reference for any synthetic biologists who are keen in developing biological 
systems with advanced complexity. In this proof of concept study, prebiotic 
sugar arabinose and rhamnose will be used to represent input A and input B 
respectively159. 
 
5.1 Predicting the Effect of Ribosome Binding Sites on Transfer Function 
of Input Devices 
A key outcome of synthetic biology is to demonstrate that reliable and robust 
engineering of synthetic biological systems can be achieved by applying 
classical engineering theorems (standardisation, modularisation, 
characterisation and abstraction) during the design process prior to system 
assembly. This could be achieved if the outcomes of genetic switches and 
logic devices, each composed of diverse biological parts, can be dependably 
predicted by forward computational approaches. Towards the design and 
optimisation of synthetic biological systems with more complicated circuitry 
and computational functions, we examined the effect of ribosome binding sites 
(RBS) on the steady state transfer function of input switch devices. By 
analysing reference data127 that had previously characterise the input-output 
relationship of genetic switches in the form of Eqn. 5.1, where A, B, C and n 
are empirically derived parameters and X is input concentration, 
 
Output Y = A + 
B(Xn)
Cn + Xn
                                                                     𝐄𝐪𝐧. (5.1) 
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
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Table 5-1. Transfer functions of input switch devices derived from 
experimental results and model prediction. Input devices marked with asterix * 
were used to derive the values of parameter A and B for other devices with the 
same inducible promoter but with different RBS.  
 
Input 
Device  A B C (mM) n R2 Ref 
pLuxR-Rbs34-
GFP* 2010.01 1.349E+05 2.890E-09 1.898 0.994 127 
pLuxR-Rbs31-GFP 969.32 7.693E+04 2.955E-09 1.771 0.999 127 
pLuxR-Rbs32-GFP 581.16 5.143E+04 3.509E-09 1.655 0.999 127 
pLuxR-RbsH-GFP 364.12 3.194E+04 3.784E-09 1.616 0.998 127 
pLuxR-Rbs34-GFP 2010.01 1.349E+05 2.890E-09 1.898 0.994 This work 
pLuxR-Rbs31-GFP 1198.15 7.693E+04 2.890E-09 1.898 0.986 This work 
pLuxR-Rbs32-GFP 801.00 5.143E+04 2.890E-09 1.898 0.965 This work 
pLuxR-RbsH-GFP 497.45 3.194E+04 2.890E-09 1.898 0.946 This work 
pBAD-Rbs34-GFP* 705.50 1.411E+05 5.240E-04 1.173 0.999 127 
pBAD-RbsH-GFP 304.56 9.229E+05 4.800E-04 1.415 0.999 127 
pBAD-Rbs32-GFP 135.41 5.208E+04 5.160E-04 1.268 0.999 127 
pBAD-Rbs33-GFP 16.77 1.290E+04 5.130E-04 1.323 0.999 127 
pBAD-Rbs34-GFP 705.50 1.411E+05 5.240E-04 1.173 0.999 This work 
pBAD-RbsH-GFP 461.45 9.229E+05 5.240E-04 1.173 0.947 This work 
pBAD-Rbs32-GFP 260.40 5.208E+04 5.240E-04 1.173 0.979 This work 
pBAD-Rbs33-GFP 64.50 1.290E+04 5.240E-04 1.173 0.983 This work 
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Figure 5-2: Predicting the transfer functions of input devices with different ribosome binding sites (RBS). Validation of the suggested forward 
engineering approach with (A) pLuxR and (B) pBAD expression systems with different ribosome bind sites upstream of GFP reporter. Solid lines 
represent the forward predicted transfer functions, with corresponding R-squared values, while symbols represent empirically-derived transfer 
functions using total experimental fitting. All the empirically-derived transfer functions have R-squared values of 0.998 or greater and are obtained 
from an earlier study by Wang et al 2011.   
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5.2 Characterisation of Input Devices 
The choice of input signals presents the first possible complication of parts 
modularity. For this reason, genetic circuits of higher complexity with multiple 
inputs often utilise promoter systems which are activated by inducers of vastly 
dissimilar chemical nature, namely IPTG, tetracycline, arabinose, 3OC12HSL 
and C4HSL. Previous studies have shown that a subset of quorum sensing 
promoters can be activated by homoserine lactone inducers of similar carbon 
chain length160. Similarly, incidences of cross-phosphorylation have also been 
observed in two component signal transduction systems between otherwise 
distinct pathways161. Thus, it is important that inducible input devices are 
carefully characterised for their steady state transfer function and pairing 
compatibility before further assembly into higher ordered logic devices.  
The arabinose inducible promoter pBAD is tightly repressed by its 
corresponding transcription factor AraC in the absence of arabinose. However, 
on induction with arabinose, pBAD undergoes conformational changes in its 
DNA structure that enables the assembly of RNAP holoenzyme and initiation 
of transcription.  While previous studies with pRHAB promoter involved genetic 
circuits that include both RhaR and RhaS transcription factors162-164, in this 
section I demonstrate that the rhamnose inducible promoter pRHAB requires 
only RhaS for full activation and displays tight regulation even when RhaS is 
overexpressed. Figures 5-3C and 5-4C show the steady state transfer 
functions of input device A, pBAD (Figure 5-3A) and input device B, pRHAB 
(Figure 5-4A) expressing RFP under strong RBS by their corresponding 
inducers respectively. 
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)LJXUH  'HVLJQ RI LQSXW GHYLFH $ ZLWK $ VWURQJ DQG % ZHDN ULERVRPH ELQGLQJ VLWHV
UHVSHFWLYHO\  ,QSXW GHYLFH$ LVPRGHOOHG DIWHU WKH DUDELQRVHLQGXFHG H[SUHVVLRQ V\VWHP ,W
FRPSULVHV RI WKH FRJQDWH $UD& WUDQVFULSWLRQ IDFWRU WKDW LV FRQVWLWXWLYHO\ H[SUHVVHG E\ WKH
S&21SURPRWHUDQGWKH LQGXFLEOHS%$'SURPRWHU,QWKHSUHVHQFHRIDUDELQRVH$UD&ELQGV
DQG WULJJHUV FRQIRUPDWLRQDO FKDQJH LQ WKH S%$' SURPRWHU WR DFWLYDWH5)3H[SUHVVLRQ 7KH
5KD6 WUDQVFULSWLRQ IDFWRU IRUXVHZLWKUKDPQRVHLQGXFLEOHH[SUHVVLRQV\VWHP LV LQFOXGHG LQ
WKHGHVLJQWRHQDEOHDFFXUDWHFKDUDFWHULVDWLRQRI LQSXWGHYLFH% LQ WKHFRQWH[WRI WKHRYHUDOO
KDOIDGGHUJHQHWLFFLUFXLW&7UDQVIHUIXQFWLRQRIS%$'SURPRWHU*UHHQWULDQJOHVUHSUHVHQW
H[SHULPHQWDOGDWDZKLOHEODFNOLQHUHSUHVHQWVHPSLULFDOO\GHULYHGWUDQVIHUIXQFWLRQIRUFRQVWUXFW
ZLWK VWURQJ ULERVRPH ELQGLQJ VLWH DV GHQRWHG LQ WKH HTXDWLRQ DERYH %OXH OLQH UHSUHVHQWV
SUHGLFWHG WUDQVIHU IXQFWLRQ IRU FRQVWUXFW ZLWK ZHDN ULERVRPH VLWH (UURU EDUV UHSUHVHQW WKH
VWDQGDUGGHYLDWLRQRIELRORJLFDOWULSOLFDWHV
 
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To examine the possibility of genetic cross-communication, I constructed 
genetic circuits that couple GFP production to pBAD activation and RFP 
production to pRHAB activation. The results showed that varying concentration 
of arabinose did not display any effect on pRHAB promoter activity (Figure 5-
5A). A similar orthogonal trend was observed in pBAD promoter with 
rhamnose (Figure 5-5B). Interestingly, the simultaneous introduction of both 
sugars modified the transfer function of each promoter slightly, which may be a 
result of differential cell growth and sugar import rate. This effect however is 
insignificant as definite ON and OFF switch behaviours are apparent, thereby 
confirming the pairing compatibility of pBAD and pRHAB promoters. 
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)LJXUH  'HVLJQ RI LQSXW GHYLFH % ZLWK $ VWURQJ DQG % ZHDN ULERVRPH ELQGLQJ VLWHV
UHVSHFWLYHO\  ,QSXW GHYLFH% LVPRGHOOHG DIWHU WKH UKDPQRVHLQGXFHG H[SUHVVLRQ V\VWHP ,W
FRPSULVHV RI WKH FRJQDWH 5KD6 WUDQVFULSWLRQ IDFWRU WKDW LV FRQVWLWXWLYHO\ H[SUHVVHG E\ WKH
S&21SURPRWHUDQGWKHLQGXFLEOHS5+$%SURPRWHU,QWKHSUHVHQFHRIUKDPQRVH5KD6ELQGV
DQGWULJJHUVFRQIRUPDWLRQDOFKDQJHLQWKHS5+$%SURPRWHUWRDFWLYDWH5)3H[SUHVVLRQ7KH
$UD& WUDQVFULSWLRQ IDFWRU IRUXVHZLWKDUDELQRVHLQGXFLEOH H[SUHVVLRQV\VWHP LV LQFOXGHG LQ
WKHGHVLJQWRHQDEOHDFFXUDWHFKDUDFWHULVDWLRQRI LQSXWGHYLFH% LQ WKHFRQWH[WRI WKHRYHUDOO
KDOIDGGHUJHQHWLFFLUFXLW&7UDQVIHUIXQFWLRQRIS5+$%SURPRWHU%OXHGLDPRQGUHSUHVHQW
H[SHULPHQWDOGDWDZKLOHEODFNOLQHUHSUHVHQWVHPSLULFDOO\GHULYHGWUDQVIHUIXQFWLRQIRUFRQVWUXFW
ZLWK VWURQJ ULERVRPH ELQGLQJ VLWH DV GHQRWHG LQ WKH HTXDWLRQ DERYH 5HG OLQH UHSUHVHQWV
SUHGLFWHG WUDQVIHU IXQFWLRQ IRU FRQVWUXFW ZLWK ZHDN ULERVRPH VLWH (UURU EDUV UHSUHVHQW WKH
VWDQGDUGGHYLDWLRQRIELRORJLFDOWULSOLFDWHV
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)LJXUH3DLUZLVHFRPSDWLELOLW\DVVHVVPHQWRI$S5+$%SURPRWHUZLWK5)3H[SUHVVLRQ
DQG % S%$' SURPRWHU ZLWK *)3 H[SUHVVLRQ 5HG VTXDUH DQG JUHHQ WULDQJOH VKRZ WKH
FKDUDFWHULVWLFV RI HDFK SURPRWHU IROORZLQJ LQGXFWLRQ ZLWK LWV QDWXUDO DQG KHWHURORJRXV VXJDU
UHVSHFWLYHO\%OXHGLDPRQGUHSUHVHQWVWKHSHUIRUPDQFHRIHDFKLQSXWGHYLFH LQWKHSUHVHQFH
RIERWKVXJDUV(UURUEDUVUHSUHVHQWVWDQGDUGGHYLDWLRQRIELRORJLFDOWULSOLFDWHV
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5.3 Model-aided Design of AND & OR Logic Gates 
To model an AND logic gate, the transfer functions of individual switch devices 
are incorporated to the following equation similar to how the effective 
resistance of a parallel arrangement of resistors is calculated.  
ANDAbs  =  [
αAND
1
TF1 + 
1
TF2
]                                                                           𝐄𝐪𝐧. (5.2) 
Where αAND is an empirically-derived parameter, and TF1 and TF2 are transfer 
functions of input switch device 1 and 2 respectively.   
 
From Eqn. 5.1, the transfer functions of input 1 and 2 are presented as, 
TF1 = A1 + 
B1(X1
n1)
C1
n1 + X1
n1                                                                           𝐄𝐪𝐧. (5.3) 
TF2 = A2 + 
B2(X2
n2)
C2
n2 + X2
n2                                                                           𝐄𝐪𝐧. (5.4) 
 
Substituting, Eqn. 5.3 and 5.4 into Eqn. 5.2, the normalised output of AND 
logic gate: 
ANDNorm = 
 [
αAND
1
TF1 + 
1
TF2
]
  lim
X1X2→∞
 [
αAND
1
TF1 + 
1
TF2
] 
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= 
 
[
 
 
 
 
 
 
1
1
A1 + 
B1(X1
n1)
C1
n1 + X1
n1
+ 
1
A2 + 
B2(X2
n2)
C2
n2 + X2
n2]
 
 
 
 
 
 
  lim
X1X2→∞
 
[
 
 
 
 
 
 
1
1
A1 + 
B1(X1
n1)
C1
n1 + X1
n1
+ 
1
A2 + 
B2(X2
n2)
C2
n2 + X2
n2]
 
 
 
 
 
 
 
                   𝐄𝐪𝐧. (5.5)          
                        
 
From Eqn. 5.3 and 5.4, as X1 and X2 approaches infinity, TF1 and TF2 are B1 
and B2 respectively. Thus, the normalised output of AND logic gate is derived 
as: 
 
ANDNorm  = [
B1+ B2
B1B2  (
1
TF1 + 
1
TF2)
]                                                      𝐄𝐪𝐧. (5.6) 
 
Table 5-2. Transfer functions of input switch devices in the modelling of AND 
& OR gates.  
 
Input Device (Rbs) A B C n Abbrev. 
pBAD-HrpS (strong) 15 3885 1.16E-4 1.983 TF1S 
pBAD-HrpS (weak) 2.8 732 1.16E-4 1.983 TF1W 
pRHAB-HrpR (strong) 45 5906 4.31E-4 0.914 TF2S 
pRHAB-HrpR (weak) 4.6 783 4.31E-4 0.914 TF2W 
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1RUPDOLVHGRXWSXWVRIIRXUK\SRWKHWLFDO$1'JDWHGHVLJQVZHUHPRGHOOHGZLWK
WUDQVIHUIXQFWLRQV IURP LQSXWVZLWFKGHYLFHVRIGLIIHULQJH[SUHVVLRQVWUHQJWK
DVOLVWHGLQ7DEOH)LJXUHVKRZVWKHSUHGLFWHGRXWSXWRIIRXUGLIIHUHQW
$1'JDWHGHVLJQV)URPWKHVLPXODWLRQWZRSRVVLEOH$1'JDWHGHVLJQVZHUH
GHULYHG E\ PDWFKLQJ LQSXW GHYLFH $ ZKLFK JHQHUDWHV +US6 WR WKH
FRUUHVSRQGLQJLQSXWGHYLFH%ZKLFKJHQHUDWHV+US57KHGHVLJQLQ)LJXUH
' ZDV IXUWKHU FKRVHQ IRU $1' JDWH DVVHPEO\ DV LW JHQHUDWHG OHVV
WUDQVFULSWLRQIDFWRUVWKXVLPSRVLQJOHVVPHWDEROLFEXUGHQRQWKHFHOO



)LJXUH  3UHGLFWHG QRUPDOLVHG RXWSXWV RI  GLIIHUHQW $1' JDWH GHVLJQV ZLWK WUDQVIHU
IXQFWLRQV FRUUHVSRQGLQJ WR $ 7)67)6 % 7):7)6 & 7)67): ' 7):
7):)URPWKHPRGHOGHVLJQ&DQG'DUHIXQFWLRQDO$1'JDWHVZKLOHGHVLJQ$DQG%PD\
H[KLELWOHDN\H[SUHVVLRQZKHQRQO\DUDELQRVHLVSUHVHQW
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To model an OR logic gate, the transfer function of individual switch devices 
are incorporated to the following equation similar to how the effective 
resistance of serial arrangement of resistors is calculated.  
ORAbs  =  [αOR (TF1 + TF2)]                                                                   𝐄𝐪𝐧. (5.7) 
 
Substituting, Eqn. 5.3 and 5.4 into Eqn. 5.7, the normalised output of OR logic 
gate: 
ORNorm = 
 [αOR (TF1 + TF2)]
  lim
X1X2→∞
 [αOR (TF1 + TF2)] 
 
 
= 
 (TF1 + TF2)
  lim
X1X2→∞
 [A1 + 
B1(X1
n1)
C1
n1 + X1
n1 + A2 + 
B2(X2
n2)
C2
n2 + X2
n2] 
                   𝐄𝐪𝐧. (5.8)       
 
Thus, the normalised output of OR logic gate is derived as: 
ORNorm  = [
(TF1 + TF2)
B1 + B2 
]                                                                      𝐄𝐪𝐧. (5.9) 
 
The normalised outputs of four hypothetical OR gate designs were modelled 
with transfer functions from 4 input switch devices of differing expression 
strength. Figure 5-7 shows the predicted output of four different OR gate 
designs. From the simulation, two possible OR gate designs were derived by 
matching input device A to input device B with similar output expression 
strength. Designs in Figure 5-7C and D were constructed and evaluated in the 
later parts of Chapter 5 and 6.  
115 
 



)LJXUH  3UHGLFWHG QRUPDOLVHG RXWSXWV RI  GLIIHUHQW 25 JDWH GHVLJQV ZLWK WUDQVIHU
IXQFWLRQVFRUUHVSRQGLQJWR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7):7)6%7)67):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7)6)URPWKHPRGHORQO\GHVLJQ&DQG'DUHIXQFWLRQDO25JDWHVZKLOHGHVLJQ$DQG%
DUHLPEDODQFHGLQWKHRYHUDOOH[SUHVVLRQSURILOH
 
&KDUDFWHULVDWLRQRI$1'/RJLF*DWH
7RGHYHORSDELRORJLFDO$1' ORJLFJDWH WKHıGHSHQGHQW+US56UHJXODWLRQ
PRWLI RI 3VHXGRPRQDV V\ULQJDH 766 VHFUHWLRQ V\VWHP ZDV UHIDFWRUHG E\
SODFLQJ WKH H[SUHVVLRQ RI +US56 WUDQVFULSWLRQ IDFWRUV LQ WZR LQGXFLEOH
H[SUHVVLRQ V\VWHPV 7KH DGYDQWDJH LV WKDW +US56 $1' JDWH RIIHUV GXDO
OD\HURIRUWKRJRQDOFRQWURO LQ(FROLKRVW7KLVPHDQVWKDW D WKHPDMRULW\RI
WUDQVFULSWLRQ HYHQWV RFFXUV YLD ıGHSHQGHQW WUDQVFULSWLRQ DQG E +US56
WUDQVFULSWLRQIDFWRUVDUHDEVHQWLQZLOGW\SH(FROL7UDQVFULSWLRQRFFXUVZKHQ
HQKDQFHUELQGLQJSURWHLQV+US6DQG+US5ZKLFKDUHUHJXODWHGE\DUDELQRVH
LQSXW$DQGUKDPQRVHLQSXW%LQGXFWLRQUHVSHFWLYHO\DUHFRH[SUHVVHGDQG
ERXQG WR WKHXSVWUHDPDFWLYDWRU VLWHVRIS+US/SURPRWHU7KLVELQGLQJHYHQW
WKHQ WULJJHUV DQ $73DVHGHSHQGHQW FRQIRUPDWLRQDO FKDQJH ZLWKLQ WKH
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promoter through a molecular interplay with the σ54-RNAP holoenyzme, 
thereby allowing RNA synthesis and elongation after the transcription start site.   
 
Designs of whole cell AND logic devices have hitherto involved the use of 
multiple plasmids101, 120, 127, 133. Towards the progression of programmable 
biological systems with advance functionalities, it is beneficial to minimise the 
usage of expression vectors and contain genetic logic gates in single plasmid 
as far as possible. Such design procedure would effectively modularise logic 
devices in a “plug and play mode”, and facilitate system transfer between 
biological chassis for diverse applications. More importantly, modularising logic 
devices simplifies the integration and evaluation of layered genetic circuits with 
multiple components – allowing smoother process for troubleshooting and fine 
tuning of genetic circuits.   
 
In this study, refactored modules of the HrpRS transcription machinery were 
systematically designed and assembled into a low copy plasmid (Figure 5-8A). 
The module which expressed GFP from pHrpL promoter was assembled 
upstream of pBAD-HrpS and pRHAB-HrpR modules to avoid any genetic 
context dependent effects that might arise from transcriptional overrun of the 
stronger pBAD and pRHAB input expression modules as a result of inefficient 
transcription termination. The “on” and “off” digital performance of the AND 
gate at steady state was qualitatively and quantitatively assessed by 
introducing inputs well above switch points in four different logic conditions 
(Figure 5-8A and 5-8B). The results showed that the AND gate was only 
activated in the presence of both inputs with approximately 900 fold 
117 
 


H[SUHVVLRQ LQFUHDVHDVFRPSDUHG WRFRQGLWLRQVZKHUHE\RQO\VLQJOH LQSXW LV
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LQSXW$
DQGUKDPQRVHLQSXW%DVVKRZQLQ)LJXUH&


$
%
118 
 



)LJXUH'HVLJQDQGFKDUDFWHULVDWLRQRIELRORJLFDO$1'JDWH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%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SHUIRUPDQFH RI $1' JDWH DW VWHDG\ VWDWH (UURU EDUV UHSUHVHQW WKH VWDQGDUG GHYLDWLRQ RI
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LQSXW$DQGUKDPQRVHLQSXW%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To assess the effect of plasmid copy number on the performance of the AND 
gate, modules which generated the HrpRS transcription activators (pBAD-
HrpS-pRHAB-HrpR) were constructed. This produces GFP output (pHrpL-GFP) 
in separate low and high copy plasmids (co-transformed with HrpRS-
generating plasmid E. coli cells). The relative GFP output of each system was 
measured (Figure 5-9A). The results showed that the AND gate system with 
GFP-producing module in high copy plasmid and HrpRS transcription 
activators in low copy plasmid produced a >4 fold higher GFP than AND gate 
systems with GFP-producing module in low copy plasmid and HrpRS (Figure 
5-9B). The result indicates that a higher concentration of HrpRS transcription 
activators, above the saturation limit of the pHrpL promoter, do not produce 
greater GFP output. It is likely that the transcriptional output of the HrpRS AND 
gate is limited by the strength of the weak pHrpL promoter. Hence, the 
conclusion is that when pHrpL-GFP module was expressed in high copy 
plasmids, intracellular availability of pHrpL promoters were increased – 
resulting in the amplification of GFP output.  
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5.5 Characterisation of OR Logic Gate 
Genetic OR gates can be achieved by designing tandem promoter genetic 
circuits or by expressing a target gene in two discrete expression cassettes. 
Nonetheless, tandem promoter OR gate circuits may fail when repression of 
downstream promoter prevents the proper functioning of the upstream 
promoter165. To develop the OR logic gate of the half adder, three prototype 
designs were constructed; two of which comprised of pBAD and pRHAB 
promoters in different tandem arrangements upstream of an RFP reporter 
gene with strong RBS, and a third design that produces RFP in two distinct 
expression cassettes (Figure 5-10A). The three OR gate designs were then 
introduced with input A and B above their switch points and assessed for the 
respective RFP outputs (Figure 5-10A and 5-10B). The results showed that 
design I and III are functional OR gates with >2500 folds higher RFP 
expression when either or both inputs were present. The OR gate design II, 
which composed of pRHAB promoter upstream of pBAD promoter and RFP 
reporter, was activated only in the presence of rhamnose but not arabinose. 
These results agree with previous finding that no expression was detected 
when pBAD promoter was fused downstream of tetracycline-inducible pTET 
promoter and upstream of a YFP reporter165.  
 
The conclusion is that this observation is likely an effect of the AraC 
transcription factor which can function as both repressor and activator. In the 
absence of arabinose, AraC when over expressed, remains bound to operator 
sites that induce DNA looping of the pBAD promoter, thereby obstructing the 
elongation of mRNA by initiated RNA polymerase. The result also suggests 
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that genetic circuits which involved tandem promoters in serial arrangement 
can be used to elucidate the biochemistry of inducible promoters and their 
associated transcription factors – exemplifying a bottom-up approach to 
understanding biology. As will be shown in Chapter 6 of this thesis, in order to 
achieve other applications of the OR gate design I, the construct was 
characterised for its steady state profile by titrating with varying concentration 
of arabinose and rhamnose (Figure 5-10C).  
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%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5.6 Conclusion 
To expand the biosensing capabilities of designer probiotics, we applied the 
synthetic biology engineering framework to develop orthogonal sets of AND 
and OR genetic logic gates that can be used as a processing interface to 
assimilate multiple input signals. As a proof of concept study, we created two 
orthogonal input devices to sense arabinose and rhamnose inputs from a 
library of standardised biological parts comprising of promoters, ribosome 
binding sites, transcription factors, gene reporters and transcription terminators. 
The input switch devices were rigorously characterised and modelled for 
different expression strength when coupled to different ribosome binding sites.  
 
While it is generally known that simple genetic switches can be modelled in the 
form of Hill-like transfer function equations (Eqn. 5.1), it remains ambiguous as 
to how the choice of ribosome binding sites will affect the overall properties of 
these transfer functions.  Herein, we verified that ribosome binding sites can 
function as direct amplifiers of reporter output in genetic biosensors, being 
most sensitive to parameters A and B when n is less than 2. Switch points of 
most inducible promoters assessed in this study were more or less coherent 
when tested with different ribosome binding sites.   
 
Next, a novel forward engineering approach was implemented to design both 
the AND and OR logic gates by considering the transcriptional machinery of 
each sub-components as orthogonal, modular units that functioned like 
resistors in wired electrical circuits. For example, the normalised output of 
AND gate which required parallel layering of HrpS and HrpR expression 
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cassettes was modelled according to the net resistance of resistors connected 
in parallel arrangement. Likewise, the normalised output of OR gate was 
modelled according to the net resistance of resistors in serial arrangement. 
From the modelling prediction, optimal designs of AND and OR gates were 
then constructed and characterised accordingly. Of note, the predicted, 
normalised output of AND and OR gate were largely congruent with the 
normalised, experimental results, with goodness of fit, R2 value > 0.9.  
 
To facilitate studies in the next chapter which required the layering of 
independent logic gates, AND and OR logic gates developed in this chapter 
were rigorously characterised in different context including genetic 
architectural designs or plasmid copy numbers. Importantly, OR gate which 
are designed from tandem promoter genetic circuits may fail when 
downstream promoters are naturally repressed by strong DNA bending 
elements. In such situation, characterisation in different genetic context is 
necessary to avoid bad designs. Finally, we showed that the expression output 
of HrpRS AND gate is limited by the strength of the weak pHrpL promoter. By 
increasing the total intracellular availability of pHrpL promoters on high copy 
plasmids, higher expression output can be generated from the HrpRS system.  
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Chapter Six 
6. PROGRAMMING AUTONOMOUS DECISION MAKING IN 
COMMENSAL MICROBE WITH BIOLOGICAL HALF ADDER 
Engineering digital operations in biological system is often far from trivial and 
requires considerable time and effort during functional testing and tuning of 
synthetic genetic circuits. Apart from the scarcity of reliable and well 
characterised biological parts, digital performances in biological system are 
further implicated by the cellular and genetic context dependent effects of the 
parts applied128, 166. Cellular context effects are fairly well understood and 
occurred as a result of genetic cross-talk between engineered circuits with the 
endogenous networks of host cell. For this reason, molecular parts and 
devices that were orthogonal to the cell native machineries with roles in either 
genetic transcription or protein translation had been created to enable 
predictable engineering of genetic circuits120, 127, 167-169. Demonstrations of 
layered genetic circuits in single cell, such as the execution of 4-input AND 
gate in bacteria120 and biological half adder and half subtractor in mammalian 
cells170 have revealed that orthogonal logic gates can be interlinked to perform 
digital operations of higher complexity and computational strength.  
 
While the capability to program cells with memory101, 110 and decision making 
functions presents many opportunities in biotechnological applications, a lack 
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of formal understanding associated with genetic context dependent effects had 
undermined our progress in engineering biology. In this respect, two studies 
have shown that the 5’ untranslated region (5’-UTR) of mRNA can affect the 
temporal control of multigene operons or inverter-based genetic circuits, and 
RNA processing using CRISPR RNA endonuclease or ribozyme can serve as 
effective genetic insulators to buffer such context dependent effects128, 129. In 
this chapter, we have sought to elucidate the limitations of engineering biology 
from an architecture point of view, with the hope of creating a general set of 
design heuristics that will serve as fundamental guidelines for the design and 
implementation of synthetic genetic circuits in the future.  
 
In this study we were interested to develop a biological half adder in 
prokaryotic systems, particularly in microbes which exhibit much faster cell 
division and cycle – so that they can be broadly applied in different 
biotechnological applications. In contrast to the mammalian half adder which 
was developed mainly for therapeutic and biosensing applications, a 
prokaryotic half adder can be used to enhance molecular process control and 
decision-making in drug and biofuel production, biosensing and 
bioremediation171, and probiotic engineering for the treatments of metabolic 
disorders18, cancer172, 173 and infectious diseases144, 174. In digital processing, 
half adders form the key building blocks for shift registers, binary counters and 
serial parallel data converters. Half adder logic can also be further connected 
in tandem to display output signals of full adder and other advanced digital 
operations such as ripple-carry adders, which may eventually pave the way for 
development of true ‘microprocessors’ in biological platforms.   
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6.1 Genetic Context Effect of σ54-dependent pHrpL promoter  
To enable sufficient expression of λCl repressor by an AND gate system, the 
gene encoding for λCl repressor was assembled downstream of σ54-
dependent pHrpL promoter on a high copy plasmid. Fortuitously, we 
discovered that pHrpL promoter located downstream of another pHrpL 
expression cassette can be turned on even in the absence of its cognate 
HrpRS transcription factors (Figure 6-3C). The converse is not true for an 
upstream pHrpL promoter (Figure 6-3B).  Negative controls with just GFP 
reporter or RBS-λCl gene upstream of pHrpL-GFP module confirmed that 
pHrpL promoter alone is not leaky and that cryptic promoter is absent in the 
λCl gene (Figure 6-3A and 6-3D).  
 
To buffer against this genetic context dependent effect of the pHrpL promoters, 
we assembled pHrpL-GFP and pHrpL-λCl modules on separate plasmids. This 
successfully prevented the genetic interference of both pHrpL expression 
modules on one another (Figure 6-3E and 6-3F). Figure 6-3G shows a 
quantitative assessment of pHrpL promoter activation due to the presence of 
another upstream pHrpL promoter and the use of plasmids as genetic 
insulators.  
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Figure 6-4: Directed evolution and characterisation of lambda repressor binding sites. (A) 
Layout of genetic circuit used in the mutation and screening of lambda repressor binding sites. 
Lambda repressor binding sites located downstream of pBAD promoter transcription start site 
(denoted with +1) are denoted as red and green letters (reverse complement). Key mutations 
that generated the best repressor in this screen are marked by green boxes. mRNA secondary 
structures from the both the original and screened repressor binding sites are shown. (B) 
Characterisation of original (blue bars) and evolved (red bars) lambda repressor binding sites 
in the engineered genetic circuit. Error bars represent the standard deviation of biological 
triplicates. 
 
As part of the development of XOR logic operations of the half adder, 
orthogonal repressor binding sites are required downstream of the OR gate 
promoters. To examine the minimal number of λCl repressor binding sites 
required for effective repression, single λCl operator site and dual λCl operator 
sites of perfect dyad symmetry downstream of pBAD promoter were fused 
before the RFP gene. The repressibility of both circuits were tested by 
generating λCl repressors from HrpRS AND gate in a separate plasmid175. 
Negligible repression was observed when only one λCl repressor operator site 
was present. In the presence of two operator sites of perfect dyad symmetry, 
RFP expression from pBAD promoter was greatly attenuated – even when λCl 
repressor was not synthesized. I postulate that the observed reduction of RFP 
expression might be caused by the presence of secondary hairpin structures 
immediately downstream of TSS acting as pseudo transcription terminator or 
locking RBS in conformations that translation initiation (Figure 6-4A).   
 
In order to examine this further, random mutagenesis on the natural sequence 
of the λCl repressor operator sites were performed and screened for mutants 
with significant difference in RFP expression levels, in the absence and 
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presence of λCl repressor. Accordingly, an evolved candidate (Cl2B) with 4 
mutations in the inverted sequence of the λCl repressor binding (Figure 6-4B) 
was obtained. Sequence comparison of the original λCl repressor binding sites 
(Cl2A) with the evolved candidate revealed that the directed evolution process 
had relieved secondary hairpin structures from 7 to 3. Next, the efficiency of 
λCl-mediated transcription termination in the context of a genetic IMPLY gate 
was studied. This was achieved by placing repressor binding sites directly 
downstream of tandem pBAD-pRHAB promoters and generating λCl 
repressors from a separate pBAD expression cassette. Two IMPLY logic 
circuits were developed which generated RFP transcripts with strong and 
weak RBS (Figure 6-5A). These were tested in both systems in the presence 
and absence of input A overtime with input B, both above switch point. The 
results showed that while IMPLY logic can be achieved from both circuits, the 
system with strong RBS exhibited higher order of expression leakiness as 
compared to that which translated RFP from weaker RBS.  
 
We characterised the steady state transfer function of the IMPLY gate with 
strong RBS by titrating cells that were activated for RFP expression by a fixed 
input of B above switch point with variable concentration of input A (Figure 6-
5C). The result shows that the IMPLY gate can be described mathematically 
by a Hill-like equation of the form  
Output Y = A + 
αB(Cn)
Cn + Xn
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Where A, B, C and n are empirically derived parameters, X is input A 
concentration, and α = 1 in presence and 0 in absence of input B above switch 
point. 
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Figure 6-5: Design and characterisation of IMPLY gate. (A) Genetic blueprint and true table of 
IMPLY gate. The IMPLY gate is designed by incorporating synthetic λCl binding sites 
downstream of OR gate promoters and regulating the expression of λCl repressors through 
the pBAD promoter. (B) Characterisation of IMPLY gate with different ribosome binding sites. 
At steady state, the IMPLY gate with a weaker ribosome binding site (RbsB) upstream of the 
RFP reporter (black stars, orange circles and purple crosses) exhibits reduced expression leak 
as compared to IMPLY gate design with a stronger ribosome binding site (red squares, green 
triangles and blue diamonds). Induction with input B, inputs A and B, or uninduced are 
represented by R, A+R and NC.  (C) Characterisation of IMPLY gates with two (blue circles) 
and four (red squares) lambda repressor binding sites. Black line represents empirically-
derived transfer function for construct with dual λCl binding sites. Error bars represent 
standard deviation of biological triplicates. 
 
Drawing insights from earlier results, we hypothesized that parameters A and 
B are parameters that are most sensitive to the overall behaviour of IMPLY 
gates when the RBS that initiate the expression of the RFP reporter are 
changed. To test this hypothesis, we simulated the output of IMPLY gates 
whereby the RFP expressions are initiated from RBS of different strengths 
(Figure 6-6). The simulation aligned with observed experimental results and 
implied that the choice of RBS can be employed as a signal moderation 
technique to achieve balance between precision tuning and output gain in 
layered logic gates. In an attempt to alleviate expression leakiness from the 
IMPLY gate with strong RBS, an additional pair of λCl repressor binding sites 
with imperfect dyad symmetry were introduced downstream of pBAD-pRHAB-
Cl2B and before the RBS-RFP module. However, the presence of 4 λCl 
binding sites completely inhibited RFP expression, resulting in failure of the 
IMPLY gate. It is likely that this failure could be an effect of pronounced 5’ UTR 
secondary structures formed due to the repeated use of identical λCl repressor 
binding sites.   
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pBAD and pRHAB by incorporating λCl binding sites downstream of both 
promoters before connecting them in tandem to elicit hypothetical OR logic as 
similar to design I. Design III was slightly altered from design II to express 
untagged, long-lived RFP. To overcome possible complication from 5’UTR 
secondary structures due to presence of multiple λCl binding sites within the 
same mRNA transcript, design IV which comprised of synthetic hybrid 
promoters of pBAD-Cl2B and pRHAB-Cl2B expressing RFPasv in two discrete 
expression cassette was also developed.  
 
Accordingly, only design IV was able to achieve well-balanced outputs which 
accurately described XOR logic operations (Figure 6-7C). While design I 
demonstrated strong suppression of RFP output in the presence of both inputs 
(arabinose and rhamnose) when characterised as an IMPLY gate (as 
described earlier), the same design failed to function in the context of XOR 
gate in which a weaker pHrpL promoter was used to drive the synthesis λCl 
repressors instead of the strong pBAD promoter. Interestingly, the results 
implied that when employing transcription repressors as molecular blockers to 
mRNA elongation, higher concentration of λCl molecules is needed to 
completely suppress transcription as λCl binding sites are engineered further 
away from the transcription start site. This observation may be an effect of 
RNAP gaining momentum as it runs down template DNA to perform 
transcription, inadvertently enabling RNAP to continue its course of action in 
the inadequacy of “molecular brakes”.  
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While both design II and III that were developed with λCl binding sites 
downstream of both pBAD and pRHAB promoters, exhibited slight semblance 
of XOR logic operations, the presence of multiple, repeated sequences of λCl 
binding sites in the transcript generated from the pBAD promoter greatly 
reduced the RFP output from Input A. Of note, using untagged RFP gene in 
design III led to slight increase in overall RFP output but did not alleviate the 
signal balancing issue due to pronounced 5’UTR structural effects. In order to 
increase the range of application for the XOR gate in the implementation of the 
half adder, design IV was characterised for its steady state profile by titrating 
with varying concentration of arabinose and rhamnose as shown in Figure 6-
7D. 
 
6.4 Characterisation of Single Cell Half Adder and Half Subtractor 
The half adder computes dual inputs with both AND and XOR logic operations 
to generate CARRY and SUM output respectively. Building on bio-logical 
devices that were modularised and rigorously characterised earlier, we co-
transformed constructs which produce GFP (CARRY) from HrpRS AND gate 
in low copy plasmid, RFPasv (SUM) from hybrid promoters pBAD-Cl2B and 
pRHAB-Cl2B and λCl repressors from pHrpL promoter in high copy plasmid 
into E. coli (Figure 6-8A). To study the digital performance of the single cell 
half adder, we characterised the system at both population wide and single cell 
level by microplate fluorescent assay (Figure 6-8B) and flow cytometry 
(Figure 6-8C) for four different logic conditions.  
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The results showed that the engineered cells exhibited robust and digital-like 
performance with minor expression leak (< 20%) in XOR output when both 
inputs were present. While previous characterisation with standalone XOR 
gate displayed near perfect XOR outputs, parallel implementation of both AND 
and XOR logic gates in half adder led to probable competition for HrpRS 
transcription activators by pHrpL promoters in both low and high copy 
plasmids – which is suggestive of expression shunting in competitive 
transcription dynamics 132. In other words, the availability of HrpRS activators 
are now divided between pHrpL-GFP module in low copy plasmid and pHrpL-
λCl module in high copy plasmid, causing both AND and XOR gates to 
perform below par than when they are operating individually. To affirm the 
hypothesis, the AND output of standalone AND gate and the AND output of 
half adder were examined using microplate fluorescent assay. The results 
showed that the GFP output of isolated AND gate was approximately 7 times 
stronger than that of half adder’s AND gate, thus confirming my hypothesis 
(Figure 6-9).   
 
It is noteworthy, that the reduced expression of GFP did not affect the overall 
performance of the half adder as effective half adder logic operations were still 
achieved. In the current single cell half adder, the engineered cells exhibited 
relatively healthy growth with the same order of viable cells (~109cfu/ml) in 
both induced and uninduced cell cultures (Figure 6-10). Nonetheless, as 
genetic complexity and heterologous expression increases, concomitant 
increase in the metabolic burden of E. coli was also observed.  
145 
 



)LJXUH(IIHFWRISODVPLGFRS\QXPEHU LQ WKHVKXQWLQJDQGVHTXHVWHULQJRI WUDQVFULSWLRQ
IDFWRUV*)3RXWSXWRISXUH$1'JDWHLVKLJKHUWKDQWKH*)3RXWSXWRIKDOIDGGHU¶V$1'JDWH
(UURUEDUVUHSUHVHQWWKHVWDQGDUGGHYLDWLRQRIIRXULQGHSHQGHQWH[SHULPHQWV

7RGHPRQVWUDWH WKHPRGXODULW\RI WKLVDSSURDFK , DOVRGHYHORSHGVLQJOH FHOO
KDOI VXEWUDFWRU E\ SHUIRUPLQJ VOLJKW PRGLILFDWLRQV WR WKH JHQHWLF FLUFXLWV WKDW
IRUPHG WKH EDVLV RI WKH KDOI DGGHU 6SHFLILFDOO\ *)3 ZKLFK H[HPSOLILHV
%2552:RXWSXWZDVSURGXFHGIURPK\EULGSURPRWHUS%$'&O%LQORZFRS\
SODVPLG LQVWHDG RI WKH S+US/ SURPRWHU )LJXUH $ $V DERYH WKH
FRQVWUXFWZKLFKJHQHUDWHG%2552:RXWSXW*)3DQGWKDWZKLFKJHQHUDWHG
WKH ',))(5(1&( RXWSXW 5)3 ZHUH FRWUDQVIRUPHG LQWR ( FROL FHOOV
&KDUDFWHULVDWLRQZDVXQGHUWDNHQDWERWKSRSXODWLRQZLGHDQGVLQJOHFHOOOHYHO
E\PLFURSODWHIOXRUHVFHQWDVVD\)LJXUH%DQGIORZF\WRPHWU\)LJXUH
& XQGHU IRXU GLIIHUHQW ORJLF FRQGLWLRQV 7KH UHVXOWV VKRZHG WKDW WKH
HQJLQHHUHGFHOOV IXQFWLRQHGDVHIIHFWLYHELRORJLFDOKDOIVXEWUDFWRUVSURGXFLQJ
146 
 


*)3RQO\LQWKHSUHVHQFHRILQSXW$DQG5)3LQWKHSUHVHQFHRILQSXW$RU%
EXWQRWZKHQERWKLQSXWVZHUHSUHVHQW



)LJXUH&HOOYLDELOLW\SURILOHRIELRORJLFDOKDOIDGGHUDIWHUKRXUVRILQGXFWLRQ(UURUEDUV
UHSUHVHQWWKHVWDQGDUGGHYLDWLRQRIIRXULQGHSHQGHQWH[SHULPHQWV
 
147 
 



 
)LJXUH'HVLJQDQGFKDUDFWHULVDWLRQRIELRORJLFDOKDOIVXEWUDFWRU$*HQHWLFEOXHSULQWRI
KDOIVXEWUDFWRU%'LJLWDOSHUIRUPDQFHRIKDOIVXEWUDFWRUDWVWHDG\VWDWH(UURUEDUVUHSUHVHQW
WKH VWDQGDUG GHYLDWLRQ RI IRXU LQGHSHQGHQW H[SHULPHQWV &)ORZ F\WRPHWU\ DQDO\VLV RI KDOI
VXEWUDFWRU < D[LV UHSUHVHQWV SRSXODWLRQ FRXQW ZKLOH ),7&$ DQG 3(&)$ UHSUHVHQW
FKDQQHOV WKDW GHWHFWV*)3DQG5)3 IOXRUHVFHQFH UHVSHFWLYHO\3RSXODWLRQVKLIWV WR WKH ULJKW
UHSUHVHQW21EHKDYLRXU
148 
 
 
 
6.5 Conclusion 
In this work, we created single cell half adder and half subtractor in prokaryotic 
system by applying classical engineering theorems (standardisation, 
modularisation, characterisation and abstraction) during the design process 
prior to system assembly. The first stage of this process was to systematically 
assemble and characterise independent modules that enable programmable 
digital operations in prokaryotic cells, including simple genetic switches, AND, 
OR and NOT logic operations. Using a forward engineering approach that is 
distinguished by rigorous characterisation and model-aided expression tuning, 
AND, OR and NOT logic gates were layered in both parallel and serial 
arrangements to generate a repertoire of cellular logic operations that includes 
IMPLY, XOR, half adder and half subtractor logic operations. Using a bottom 
up approach for constructing biological systems of increasing complexity we 
assessed genetic architectures that led to genetic context dependent effects. 
On this basis, the significance of each design on the overall digital 
performance of programmable logic gates in engineered cells was studied.  
 
Of all, the presence of secondary structures in 5’-UTR of mRNA affects 
genetic expression the most.  We discovered that the presence of seven 
consecutive hairpins immediately downstream of promoter transcription start 
site would cause severe impediment of gene expression. Although OR gate 
design made up of tandem promoters can be subjected to the undesirable 
effects of 5’-UTR secondary structure, we showed that that the effect is not 
pronounced in the digital performance of OR logics when the promoters and 
DNA operator sites involved are of markedly different DNA sequences. The 
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OR gate design that comprises a separate gene expression cassette also 
reliably demonstrates digital operation. However, the involvement of larger 
DNA modules and repetitive use of transcription terminators that are rich in 
secondary hairpin structures may impede system assembly in terms of 
construction efficiency and accuracy. Where identical DNA sequences are 
incorporated in a single mRNA transcript, as shown in design II and III of XOR 
gate, the effect of 5’-UTR secondary structure preventing gene expression is 
significantly more pronounced. Thus, it is proposed that XOR gate logics in 
layered genetic circuits should be designed with two discrete expression 
cassette instead of employing a tandem promoter circuit design. It would also 
be interesting to test if RNA processing tools can be employed in multiplex 
mode to insulate the myriad of biological devices from RNA genetic context 
dependent effects in layered genetic circuits concurrently.  
 
Transcription terminators are important insulators to modularise independent 
expression cassettes. Still, if transcriptional overrun is present, even with the 
use of the strongest known transcription terminator, or when the choice of 
parts is limited by DNA length or synthesis capability, the problem can be 
overcome elegantly from an architecture perspective. This can be achieved by 
designing the most sensitive component in a reverse direction or placing it 
directly upstream of other expression modules – such that transcription 
overrun can never occur. In this study, the second method was applied, 
leading to the successful development of a biological AND gate. This was 
done by having the pHrpL-GFP reporter device upstream of other modules 
which generated HrpRS transcription factors.  
150 
 
 
 
Perhaps of particular interest, I discovered that σ54 promoters can exhibit 
genetic context dependent effects if two σ54 promoters are placed close to 
each other. Previously, σ54-dependent NtrC-binding promoters have been 
reported which permit transcription in vitro in the absence of enhancer-binding 
proteins and ATP. These include conditions that promote DNA melting, such 
as DNA supercoiling, temperature rise and lower ionic strength, or when 
characteristic point mutations are implemented on the σ54 protein 177, 178. Here, 
I show that an upstream σ54 pHrpL promoter could also activate downstream 
pHrpL promoter in vivo if the two promoters are of close proximity – possibly 
as a result of plasmid DNA supercoiling. This undesired switched-on activity 
can be avoided by designing pHrpL expression modules in different plasmids, 
i.e. to use plasmid as genetic buffers to insulate such genetic context 
dependent effects. As perturbations in genetic expression may propagate 
sizable effects on genome-wide transcriptional responses, it is worth 
considering if an additional role of plasmid in the course of evolution is to 
provide more robust and stringent control to genetic expression as with the 
occurrence of multiple chromosomes.  
 
While recombinases have been intelligently crafted into Boolean logic gates 
with DNA-encoded memory functions, it is important to note that biosensors 
connected in AND, OR and XOR operations with recombinase-based logic 
gates may not be able to distinguish inputs from different environment and 
provide the desired response.  For example, a probiotic that is genetically 
programmed in AND logic to sense two inputs such as hypoxia and low pH 
may be activated for hypoxia and low pH signals in two different location, as 
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compared to sensing both signals in situ. The same may be applicable for 
other logic operations with recombinase-based logic gates. Thus, layered 
genetic circuits that are capable of sensing and providing location-sensitive 
Boolean logic operations are still useful in programming cellular behaviours. Of 
particular interest is a combination of layered genetic circuits with the 
synthesis of recombinases as intermediary output, this may provide a novel 
and better platform for programmable cellular behaviour with both accuracy 
and memory.     
 
The implementation of synthetic genetic circuits with the complexity of half 
adder and half subtractor may represent the extent to which synthetic 
biologists can currently engineer such circuits in single E. coli cell without 
causing an excessive metabolic load onto the cell. Nature, over many years of 
evolution, has produced specialised cells that perform specific and 
differentiated roles. Drawing inspiration, perhaps a practical way towards the 
development of synthetic biological systems that could perform sophisticated 
logic operations such as full adders and ripple adders is to implement a 
network of intercommunicating cells, each capable of  performing specialised 
half adder logic operations.  
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Chapter Seven 
7. OVERVIEW AND FUTURE WORKS 
 
7.1 Summary of Contributions 
In this thesis, I made the following contributions  
 
A) Genetic engineering of commensal microbe to sense and eradicate a 
common superbug pathogen, Pseudomonas aeruginosa. A prototype of 
designer probiotic to combat superbug infection was developed by 
reprograming human commensal E. coli with genetic devices that enabled E. 
coli to sense quorum sensing molecules from P. aeruginosa, produce 
corresponding killing molecules, and release the accumulated killing molecules 
through self-lysis to eradicate the pathogen. The sensing, killing, and lysing 
devices were characterised to elucidate their functionalities, which 
subsequently aided in the construction of the final system and the verification 
of its designed behaviour. Based on the characterisation and modelling results, 
the sensing device was verified to display an optimal activity approximately in 
the range of 1.0E-7 to 1.0E-6 M 3OC12HSL, which was in line with the 
concentration of 3OC12HSL secreted by P. aeruginosa. The activities of the 
killing and lysing devices were also confirmed in response to this range of 
3OC12HSL concentration. The engineered E. coli with the complete system 
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was effective in killing planktonic P. aeruginosa by 99% and prevented its 
transition into sessile state by 90% when those two microbes were grown 
together.  
 
B) Development of genetic interfaces that could integrate multiple input 
signals for enhanced biosensing capabilities. The influence of ribosome 
binding sites on the output expression of biosensors or switch devices were 
elucidated and could be accurately modelled using Hill-like equation – a 
logistical function which describes output genetic expression as a function of 
input inducer concentration.  A forward engineering framework involving 
characterisation of only the essential information of input biosensors and 
model-aided design principles were created to guide the predictable and 
reliable engineering of AND & OR logic gates in commensal E. coli bacteria. 
Using this novel design approach, the normalised outputs of actual AND & OR 
logic gates assembled in this study were comparable to outputs predicted from 
the steady state transfer function models, with least square regression fittings 
of at least 0.90. Single cell, single plasmid AND & OR logic gates were 
constructed in commensal bacteria and characterised to study how genetic 
context dependent effects could occur through choices of genetic architectures.  
 
C) Programming autonomous decision-making in commensal microbe 
with biological half adder. Using a forward engineering approach that is 
supported by rigorous characterisation and model-aided expression tuning, 
AND, OR and NOT logic gates were layered in both parallel and serial 
arrangements to generate a repertoire of cellular logic operations that includes 
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IMPLY, XOR, half adder and half subtractor logic operations. Through bottom 
up approach of constructing biological systems of increasing complexity, 
genetic architectures that led to genetic context dependent effects were 
carefully assessed. On this basis, the significance of each design on the 
overall digital performance of programmable logic gates in engineered cells 
was studied. The design heuristics established in this study will be invaluable 
guidelines to future designs and implementations of synthetic genetic circuits. 
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7.2 Future Work 
Probiotic engineering represents a novel antimicrobial strategy. The proposed 
research presents a systematic and rational framework to treat microbial 
infections through the engineering of probiotic E. coli. Issues that previously 
reduce the effectiveness of conventional antibiotic treatments are addressed 
with the introduction of functionalities such as biofilm disruption and pyocin 
antimicrobial modules. Pyocin-based antimicrobial strategies are narrow 
spectrum and effective only against closely related species. Moreover, pyocin 
production can be rewired to be under the regulation of multiple input signals 
using the biological AND & OR genetic interfaces developed earlier. As a 
result, exclusive killing of P. aeruginosa could be achieved without collateral 
damage to beneficial gut flora during the treatment process. These signals can 
be other biomarkers of the pathogen, including other quorum sensing signals 
4-hydroxy-2-alkylquinolines and N-butanoyl-L-homoserine lactone, and toxins, 
or signals that are deliberately introduced via edible prebiotic sugars.  
 
One way to improve the efficacy of designer probiotics in treating superbug 
infection is to infuse commensal bacteria with the ability to swim and seek out 
elusive bacterial infections that are unreachable by conventional antibiotics. To 
mediate this mechanism, a biological half adder can be coupled to regulate the 
motility of engineered commensal bacteria. Specifically, biosensors that 
recognise two different input quorum signals will drive the propulsion of 
engineered commensal towards the pathogen in three dimensional space. 
Then, when positioned within proximity to target pathogen whereby 
concentration of both input signals are maximum, the motility mechanism in 
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engineered commensal is deactivated as exhibited in the output of XOR gate. 
The AND gate command can then be activated for the production and release 
of pyocin antimicrobial modules. For protection against gastrointestinal tract 
infections in immunocompromised and surgical patients, the probiotic-based 
infection defence can be either consumed as a health supplement or 
encapsulated within a specialised pharmaceutical carrier. 
 
It is envisioned that the framework developed in this study could be readily 
applied to the treatment of other infectious diseases such as Vibrio cholera 
and Staphylococcus aureus, and ultimately lead us toward the development of 
a probiotic strain that is able to diagnose and treat multiple infections. This can 
be achieved by rewiring probiotic bacteria with novel biological devices to 
sense and analyse quorum signals from various pathogens, leading to the 
production of specific antimicrobials against the superbugs. Through this 
research, I hope to provide an exemplary model on the engineering of 
probiotic with multiple functionalities and intensify the global research efforts 
toward bacterial therapy. The development of probiotic strains that are 
equipped with user-defined functions for treating infectious disease requires 
the amalgamation of microbiology and functional genomics with the novel field 
of synthetic biology. Henceforth, synthetic biology approaches, such as system 
assembly and bioinformatics analysis, will be employed in concert with 
conventional microbiology and functional genomics techniques, such as 
transcriptome and proteome profiling and gene knockout.  
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only a handful of studies had successfully engineered micro-organism with the 
ability to swim towards specific molecules that are not natural chemo-
attractants of E. coli180, 181. This limitation is perpetuated by two reasons; firstly, 
work in rewiring genetic circuits to control bacterial motility is considered 
laborious and costly due to a lack of assembly framework to facilitate 
systematic construction of advanced biological system. Secondly, because 
bacteria chemotaxis is regulated by other innate chemotaxis signalling 
cascade, a synthetic chemotaxis system might be subjected to noise and 
failure in an environment when both natural and non-natural chemotaxis 
molecules are present182. Similarly, the lack of studies on soluble enzymes 
which are effective in breaking the biofilm of both mucoid and non-mucoid 
strains of Pseudomonas is a major obstacle in the development of probiotic-
based therapy.  
 
Proposed Approach:  
(a) To develop an E. coli strain that is isolated from its native chemotaxis 
signalling cascade, gene knockout can be performed with the targetron-based 
gene knockout technique to remove component that is interconnected with 
innate chemoeffectors183. Figure 7-1 shows the sensory cascade of E. coli 
chemotaxis and a list of major transmembrane chemoreceptor proteins (MCPs) 
involved in chemotactic response. As downstream chemotactic proteins are 
able to self-phosphorylate184, the deletion of motility proteins such as CheA 
and CheW will decouple the influence of native MCPs to bacterial motility 
without disabling the flagella motor. Further, to confirm the decoupling, primer 
walking and chemotaxis assay on motility agar will be implemented185.  
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(b) Bacterial stators are torque-generating devices for flagella rotation, 
powered by either proton motive force (pmf) or sodium motive force (smf). 
Given that proton energetic is crucial to E. coli metabolism and that vastly 
different pH environment exists along the GI tract, smf-driven bacterial stators 
can be employed in place of native pmf-driven stator to avoid dysregulation of 
critical life processes in the engineered biological system.  
 
(c) To enable the engineered E. coli to swim towards P. aeruginosa, proteins 
that regulate cell motility such as CheZ can be rewired under the regulation of 
Pseudomonas quorum sensing controller. Bacterial motility can be analysed 
using techniques as described above, as well as phase contrast microscopy in 
specially designed capillary tubes.  
 
(d) Pseudomonas biofilm matrix is encased in an extracellular polymeric 
substance comprising of nucleic acids, proteins and polysaccharides186. 
Consequently, genes encoding for biofilm degradation proteins can be 
independently tested for biofilm degradation. For high throughput biofilm 
degradation assay, Pseudomonas biofilms can be cultivated on microtiter plate 
and treated with lysed supernatant of recombinant proteins. Biofilm can be 
quantified in terms of film dry mass and CFU count of viable biofilm cells after 
treatment. Table 7-1 presents a list of biological parts which can be developed 
and characterised for the proposed research.   
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Table 7-1. List of potential biological parts for engineered motility and P. 
aeruginosa biofilm disruption. 
 
Biological Part Function Reference 
Stator component 
pomA 
Component of sodium-driven 
flagella stator derived from V. 
alginolyticus 
187 
Stator component 
potB 
Component of sodium-driven 
flagella stator derived from E. coli 
and V. alginolyticus 
187 
Direction controller 
CheZ 
Modulate bacteria tumbling and 
forward propulsion through 
rotation of  bacteria flagella  
188 
Bovine Pancreatic 
DNase I 
Catalyse hydrolysis of 
phospodiester bonds in nucleic 
acids 
189, 190 
Alginate Lyase 
algL 
Catalyse cleavage of 4-O-linked 
glycosidic bonds between the 
urinate residues of alginate 
191 
 
Potential Difficulties:  
(a) Production and degradation of motility proteins in the engineered E. coli 
may be too slow to effectuate a sensitive and responsive pseudotaxis. For this, 
the transcriptional regulation of motility proteins can be coupled to a genetic 
amplifier to enhance protein synthesis rate. In addition, motility proteins can be 
tagged with protease-recognition tag to promote faster protein turnover.  
 
(b) Biofilm degradation protein may not be soluble in the engineered E. coli, 
leading to poor yield of active forms during over expression. To enhance 
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soluble protein production, folding chaperon or solubility tags such as GST 
fusion tag can be co-expressed with the protein of interests192.   
 
7.2.2 Engineer genetic circuits to regulate the bacterial motility and 
biofilm disruption for in vitro studies.  
Motivation: While individual biological parts can be assembled and 
characterised by traditional genetic engineering techniques, the assembly or 
analysis of larger biological systems are challenged by the constraint of 
available cloning sites on plasmid vectors. That is, cloning sites are expended 
with the inclusion of each promoter, ribosomal binding site, protein encoding 
gene and terminator sequence, in turn supporting only the development of 
small biological systems. Clearly, to enhance the effectiveness of the 
proposed treatment strategy, the engineered E. coli will entail laborious 
addition and optimisation of multiple genes. Moreover, as the concerted 
expression of various genes regulated by the same quorum sensing receiver 
may be lower than when they are expressed in isolation, in vitro studies are 
required to assess the performance of engineered bacterial motility and biofilm 
disruption before integration into the final system (sensing, swimming, killing 
and biofilm disruption).  
 
Proposed Approach:  
(a) Higher-ordered devices and system can be mathematically modelled using 
elementary data collected from parts’ characterisation. Results from the 
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computational models will aid in the optimisation of the overall system and 
identify devices that require further refinement.  
 
(b) The proposed biological system, integrated with both motility and biofilm 
disruption functions, can be assembled using the standardised synthetic 
biology framework. This framework involves the assembly of biological parts 
into sub-system constructs known as ‘devices’ and finally the assimilation of 
multiple devices into an advanced biological system.  
 
(c) To test the engineered E. coli for directional motility, synthetic acyl 
homoserine lactone molecules (AHL) can be layered onto agarose plate to 
create motility agars with differential AHL gradient. Next, the engineered E. coli 
can be spotted onto different points of the motility agar and assessed for 
bacterial movement. Results of swimming distance and direction can be 
captured and analysed with relevant imaging software. Further, to test motility 
on liquid media, specially designed microfluidic device can be fabricated193. 
The device consists of an input for engineered E. coli and three sampling 
output, containing different concentration of AHL. Cells at each sampling 
output will be quantified by CFU count.  
 
(d) To test the engineered E. coli for Pseudomonas biofilm disruption function, 
mature biofilms of P. aeruginosa isolate ln7 can be cultivated on reconstituted 
human epithelium tissues and treated with engineered E. coli cells. The 
efficiency of biofilm disruption can be quantified by CFU count and visualised 
by confocal laser scanning microscopy.  
163 
 
 
 
(e) To test whether the engineered E. coli can sense, swim towards and 
destroy Pseudomonas biofilm, a mutant strain of ln7 (ln7∆LasI) will be created 
by knocking out LasI gene encoding for AHL synthase. Next, biofilms of ln7 
and ln7∆LasI will be allowed to develop at the sampling output of the 
microfluidic device before the engineered E. coli is introduced at the input. The 
hypothesis is that only the biofilm of ln7 will be disrupted as the engineered E. 
coli will only swim toward ln7.      
 
Potential Difficulties:  
(a) Engineered genetic circuit that shares a common input for divergent 
outputs may result in output signals below desired values. For this, signal 
amplification by means of orthogonal promoters may be utilised to circumvent 
the problem.  
 
(b) Homogenous samples of Pseudomonas biofilms on reconstituted human 
tissue maybe difficult to cultivate. For this, special maintenance medium and 
incubator with precise air quality, humidity and temperature controllers may be 
required. 
 
7.2.3 Transfer the engineered biological system into a probiotic E. coli 
host for in vivo murine studies.  
Motivation: Promising treatment strategies for human diseases such as 
cancer, HIV and bacterial infections, must be tested in animal models before 
they are endorsed for further evaluation on a human body. This legislative 
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requirement is fulfilled so as to enhance the understanding of potential benefits 
and complications associated with the novel treatment method, and ensure 
that human health is not compromised for human clinical trials later. Further, 
because the environmental and growth condition of animals are easy to control, 
animal studies provide relatively accurate insights on the in vivo treatment 
efficiencies analogous to that of human vertebrates. Animals for pre-human 
clinical trials are selected in terms of their size, lifespan, cost and genetic 
likeness to human. For this reason, mice are the most widely utilised 
mammalian animals for clinical research and will be employed for the testing of 
the engineered probiotic in treating P. aeruginosa infections. 
 
Proposed Approach:  
(a) For treatment against P. aeruginosa in the mature biofilm state, a probiotic 
strain of E. coli (Nissle 1917), can be chromosomally engineered with sensing 
and therapeutic features discussed in this thesis (Chapter 4 – 7). Two reasons 
underline the choice of this probiotic strain; firstly, strains from the E. coli 
genus are well characterised for diverse microbiological properties. With 
relevant bioinformatics and metabolic pathways fully accessible in online 
databases, the adoption of E. coli for probiotic engineering is more predictable 
and cost-effective. Secondly, because Nissle 1917 is originally a human 
isolate, the strain is able to colonise the gastrointestinal tract more readily, 
further advocating the use for treatment against GI infections.  
 
(b) Murine studies should be performed following strict compliance to protocols 
and guidelines as approved by relevant bioethics committee. Germ-free mice 
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may be used as relevant murine models. To enable pathogen colonization of 
the GI tract, overnight cultures of P. aeruginosa clinical isolate ln7 can be fed 
to mice in sterile environment. Following, the infected mice are treated with the 
engineered probiotic at periodic intervals after infection. The efficacy of 
treatment may be quantified using viable cell counts of the target pathogen 
from homogenised mice tissues174.  
 
(c) To trace the colonization of P. aeruginosa and engineered probiotic in the 
GI tract of infected mice, whole-body imaging techniques may be applied194. 
For this, a strain of ln7 that is able to constitutively express green fluorescent 
protein (ln7-GFP) can be used. To visually differentiate the engineered 
probiotic from P. aeruginosa, a plasmid that constitutively express red 
fluorescent protein can be transformed into the engineered probiotic (EC-RFP). 
Subsequently, to monitor the extent of biofilm development, the infected mice 
can be viewed under fluorescent microscope at regular interval until adequate 
fluorescence is observed. Finally, to visualise the effectiveness of the 
proposed treatment, the infected mice can be examined with dual-color imager 
at regular intervals.  
 
Potential Difficulties:  
(a) Gene knockout: gene knockout in E. coli Nissle 1917 maybe exhibit low 
efficiency due to poor competency of Nissle 1917 in vector transformation. 
This issue may be addressed by using CRISPR technology and mediating 
vector transfer by inter-bacterial conjugation.  
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(b) Chromosomal insertion may lead to many false positives due to 
complication in removing the antibiotic selection marker. This issue can be 
addressed by increasing the frequency of marker removal through additional 
rounds of antibiotic removal and selection.  
 
(c) Fluorescent reporters from P. aeruginosa and engineered probiotic may be 
too weak to be detectable in the infected mice. Consequently, the removal of 
mice surface hair or skin, or the use of stronger fluorescent protein such as the 
superfolder GFP may be necessary195.     
 
7.3 Socio-Ethical Aspects of Designer Probiotic and Its Adoption  
In many countries, probiotics are classified as functional foods and made 
available in the form of encapsulated health supplements or yogurt. As such, 
these products are not subjected to the tight regulation associated with 
pharmaceutical drugs and medical food. With the advent of synthetic biology 
and the human microbiome project, newly acquired knowledge about the 
human health and gut microbiota may see the development of probiotics being 
genetically functionalised with novel therapeutic features and control elements 
– designer probiotics. Just like genetically modified (GM) foods, designer 
probiotics would inadvertently be under tighter scrutiny and regulation, leading 
to divisive opinions about their use and relevance. Perhaps one contentious 
issue about designer probiotics is whether the products would introduce 
unintended health repercussions in the long run. To the common folks, 
genetically modifying foods introduce an unnatural and potentially harmful 
flavour into them. These concerns are rightfully justified, given the untended 
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outcomes of GM corps which surfaced only years after their adoption. These 
includes gene flow through horizontal gene transfer, development of pesticide 
resistance, and uncontrolled escape of modified crops into the environment.  
 
To maximise the potential of designer probiotics in advancing human health, it 
is imperative that the product development cycle is accompanied by a detailed 
analysis of the potential benefits and risks associated with its use. An ethical 
assembly consisting of clinicians, health professionals, synthetic biologists, 
social scientists, and representatives from food industry and government could 
be formed to brainstorm and develop safety nets on the testing and adoption 
of designer probiotics. Ideally, probiotics should be modified as little as 
possible, introducing only essential features that either boost therapeutic 
efficacy or enable human-imposed control. Human-imposed control such as 
the design and implementation of genetic kill-switch in this thesis serves as 
secondary control to prevent the unintentional escape of designer probiotics. 
As with medical foods and pharmaceutical products, designer probiotics ought 
to be subjected to tight regulation and testing before being endorsed for 
clinical adoption. Human clinical trials should be performed in gradual phases 
of at least 20, 100 and 1000 people in double-blinded, randomised, placebo-
controlled trials. Results of clinical trials should be transparently communicated 
to the public while avoiding the use of technical jargons that may otherwise 
lead to more distrust and confusion. Scientists should also be ready to 
acknowledge public views that are based on socio-cultural aspects rather than 
scientific accuracy and be patient to engage in constructive dialogues with the 
public.    
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Chapter Eight 
8. APPENDIX A - RECIPES 
Appendix A provides the list of materials that were used to perform each experiment 
as described in Chapter 3. 
 
8.1 Recipes – Therapeutic Microbe against Pseudomonas Infection  
8.1.1 Gibson Assembly 
1. Thermocycler 
2. Gel electrophoresis setup  
3. UV transilluminator 
4. Heating block 
5. Nanodrop (Thermo Scientific) 
6. Electroporator 
7. Isothermal water bath 
8. Shaking incubator  
9. Sterile scalpel 
10. Microcentrifuge tubes 1.5 ml 
11. PCR reaction tubes  
12. Electroporation cuvette 2.0 mm  
13. L-shape cell spreader 
14. Round bottom cell culture tubes with cap  
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15. Phusion High Fidelity DNA polymerase (New England Biolabs), 5× Phusion 
HF buffer, DMSO, dNTPs. 
16. 1× TAE buffer (40 mM Tris base, 40 mM acetic acid, 1 mM EDTA) from 
10×Tris-Acetate-EDTAbuffer.Top up to 1L with sterile deionized water.  
17. 0.8% w/v agarose gel with 8-wells in 55 ml 1× TAE and 1× nucleic acid gel 
stain. This is sufficient for loading of up to 50μl of PCR product. 
18. QIAquick Gel Extraction Kit (Qiagen) 
19. Gibson Assembly Master Mix (New England Biolabs). Alternatively, a 5× 
isothermal reaction buffer (ISO) and1.33× assembly master mix can be 
prepared with the recipe formulated by Gibson as described in Table 8-1 
and 8-2150.The 5× ISO buffer and 1.33× assembly master mix can be 
stored at -20 oC in aliquots of 350 µl and 15 µl for up to a year respectively. 
20. SOC medium (0.5% w/v yeast extract, 2% w/v tryptone, 10 mM NaCl, 2.5 
mM KCl, 10 mM MgCl2, 10 mM MgSO4, 20 mM glucose). Glucose is added 
last after autoclaving the other ingredients. Sterilize the solution with a 0.20 
µm filter and stored at 4 °C. 
21. Chemically competent E. coli cells 
22. Antibiotic-supplemented LB agar plate  
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Table 8-1. Preparation of 5× isothermal buffer (ISO) 
 
Initial Concentration Volume in 6 ml 
Final 
Concentration Source  
Sterile ddH2O Top up to 6 ml   
Tris-HClpH7.5  (1 M)  3 ml 500 mM  
MgCl2 (2 M) 150 µl 50 mM  
dNTP mix (10mM of ea. dNTP) 600 µl 1 mM of ea. dNTP  
DTT (1 M) 300 µl 50 mM Thermo Scientific 
NAD (100 mM) 300 µl 5 mM Applichem Lifescience 
PEG-8000  1.5 g 25% w/v Affymetrix 
 
 
 
 
Table 8-2. Preparation of 1.33× assembly master mix 
 
Initial Concentration 
Volume in  
1.2 ml 
Final 
Concentration Source  
Sterile ddH2O Top up to 1.2 ml   
ISO buffer (5×) 320 µl 500 mM  
T5 exonuclease (10 U/µl) 0.64 µl 6.4 U New England 
Biolabs 
Phusion polymerase  
(2 U/µl) 
20 µl 40 U New England 
Biolabs 
Taq Ligase (40 U/µl) 160 µl 6400 U New England 
Biolabs 
 
8.1.2 Characterisation of Quorum Sensing Device 
1. Shaking incubator  
2. Microplate reader with programmable time-based fluorescence and 
absorbance measurement functions. (Biotek, Synergy HT Multi-Mode 
Microplate Reader recommended) 
3. Gen5 Data Analysis software (Biotek, software for Synergy HT microplate 
reader) 
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4. Matlab with Curve Fitting Toolbox (The Mathswork, Natwick) 
5. MS Excel (Microsoft Office 2010 or equivalent) 
6. Multi-channel pipette 
7. Vortex 
8. Microplate sealing film  
9. Round bottom cell culture tubes with cap  
10. Petri dishes 
11. 1 L of supplemented M9 characterisation media (1× M9 salts, 1 mM 
thiamine hydrochloride, 0.4% v/v glycerol, 0.2% w/v casein hydrolysate, 2 
mM MgSO4, and 0.1 mM CaCl2, Table 8-3). Sterilize the solution with a 
0.20 µm filter and store at 4 °C away from light. 
12. 3OC12 homoserine lactone. Dissolved in absolute DMSO to a stock 
concentration of 10 mM.Obtain 3OC12HSLtest solutions (0.1 µM, 1 µM, 10 
µM,0.1 mM and 1 mM) by sequential 10× dilution in supplemented M9 
characterisation medium (10 µl 3OC12HSL solutions to 90 µl supplemented 
M9)  
13. Fresh plate of E. coli that expresses green fluorescent protein (GFP) when 
induced with 3OC12HSL (QS-GFP, Ampr) 
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Table 8-3. Preparation of characterisation media (M9S) 
 
Initial Concentration Volume in 1 L 
Final 
Concentration 
5× M9 minima salts 5.64 g 1× 
Thiamine hydrochloride  150 mg 1 mM 
MgSO4 (0.1 M) 20 ml 2 mM 
CaCl2 (0.5 M) 200 µl 0.1 mM 
Casein hydrolysate (10% 
w/v) 
20 ml 0.2% w/v 
Glycerol (50% v/v) 8 ml 0.4% v/v   
Sterile ddH2O Top up to1 L  
 
8.1.3 Estimation of Native Autoinducer Produced by P. aeruginosa 
1. Shaking incubator  
2. Microplate reader with programmable time-based fluorescence and 
absorbance measurement functions. (Biotek, Synergy HT Multi-Mode 
Microplate Reader recommended) 
3. Gen5 Data Analysis software (Biotek, software for Synergy HT microplate 
reader) 
4. MS Excel (Microsoft Office 2010 or equivalent) 
5. Multi-channel pipette 
6. Vortex 
7. Microplate sealing film  
8. Round bottom cell culture tubes with cap  
9. Membrane filters 0.2 µm   
10. Syringes 5 ml  
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11. 1 L of supplemented M9 characterisation media (1×M9 salts, 1 mM 
thiamine hydrochloride, 0.4% v/v glycerol, 0.2% w/v casein hydrolysate, 
2mM MgSO4, and 0.1mM CaCl2, Table 8-3). Sterilize the solution with a 
0.20 µm filter and store at 4°C away from light. 
12. Clinical isolates of P. aeruginosa ln3, ln4, ln5, ln7, ln8 and lnB (Ampr) 
13. Fresh plate of E. coli that expresses green fluorescent protein (GFP) when 
induced with 3OC12HSL (QS-GFP, Ampr) 
 
8.1.4 Characterisation of Lysis Device 
1. Shaking incubator  
2. Microplate reader with programmable time-based absorbance 
measurement functions. (Biotek, Synergy HT Multi-Mode Microplate 
Reader recommended) 
3. Gen5 Data Analysis software (Biotek, software for Synergy HT microplate 
reader) 
4. Mini-PROTEAN Tetra Cell electrophoresis chamber and power supply  
5. MS Excel (Microsoft Office 2010 or equivalent) 
6. Incubator  
7. Microcentrifuge 
8. Multi-channel pipette 
9. Vortex 
10. Microplate sealing film  
11. Round bottom cell culture tubes with cap  
12. Petri dishes 
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13. 1 L of supplemented M9 characterisation media (1× M9 salts, 1 mM 
thiamine hydrochloride, 0.4% v/v glycerol, 0.2% w/v casein hydrolysate, 2 
mM MgSO4, and 0.1 mM CaCl2, Table 8-3). Sterilize the solution with a 
0.20 µm filter and store at 4°C away from light. 
14. 3OC12 homoserine lactone. Dissolved in absolute DMSO to a stock 
concentration of 10 mM. Obtain 3OC12HSLtest solutions (0.1 µM, 1 µM, 10 
µM, 0.1 mM and 1 mM) by sequential 10× dilution in supplemented M9 
characterisation medium (10µl 3OC12HSL solutions to 90 µl supplemented 
M9)  
15. Membrane filters 0.2 µm   
16. Syringes 5 ml  
17. Ice bath 
18. Absolute trichloroacetic acid 
19. Reconstitution solvent  20 ml  (1× PBS buffer pH 7.0, 30 mM imidazole, 4 
M urea pH 6.0) 
20. Vivapure miniprep MC (Sartorius Stedim Biotech GmbH) 
21. Bradford protein assay kit (Thermo Scientific) 
22. Precast SDS PAGE gel (Biorad) 
23. Fresh plate of E. coli with  Sense-Release functions when induced with 
3OC12HSL (QS-E7, Ampr) 
24. Fresh plate of E. coli with Sense-Kill-Release functions (QS-E7, Ampr) 
25. Fresh plate of E. coli with Sense-Kill functions (QS-S5, Ampr) 
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8.1.5 Electron Microscopy Analysis of E. coli Cytoplasmic Release 
1. Shaking incubator  
2. Centrifuge 
3. Microcentrifuge with refrigeration function 
4. Vacuum dryer 
5. Osmium plasma coater  
6. Field emission scanning electron microscope (FESEM) 
7. Round bottom cell culture tubes with cap 
8. Microcentrifuge tubes 2.0 ml 
9. Membrane filters 0.2 µm   
10. Syringes 5 ml  
11. 24-well microplate plate  
12. Tweezer 
13. 10 ml of LB broth with ampicillin (100 µg/ml). 
14. PEI-coated silicon slide. To prepare a silicon substrate for SEM application, 
first clean the surface of a silicon slide with 70% v/v ethanol solution and 
blow free of dust with an air hose. Immerse the slide in polyethyleneimine 
(PEI) for 30 min before rinsing completely with sterile deionized water 2 – 3 
times. Leave to dry on a clean bench for at least 3 h or until use. PEI-
coated slides can be stored in for up to two weeks at room temperature.  
15. 0.1 M sodium cacodylate,pH7.4  
16. 2.5% w/v glutaraldehydein 0.1 M sodium cacodylate, pH7.4 
17. 1% w/v osmium tetraoxide in 0.1 M sodium cacodylate, pH7.4 
18. Ethanol solutions (37%, 67%, 95% and 100%), 5 ml of each. 
19. SEM coating powder, gold-palladium alloy (60:40) 
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20. Fresh plate of engineered E. coli with Sense-Kill-Release functions (QS-
S5-E7, Ampr) 
21. Control plate of engineered E. coli with only Sense-Kill functions (QS-S5, 
Ampr) 
 
8.1.6 Overlay Inhibition Assay 
1. Kitchen microwave 
2. Incubator with shaking function 
3. Isothermal water bath 
4. Bio-imager (Biorad ChemiDoc XRS or equivalent) 
5. Round bottom cell culture tubes with cap 
6. Microcentrifuge tubes 2.0 ml 
7. Membrane filters 0.2 µm  
8. Syringes 5 ml 
9. Tryptic soy agar plates (3% w/v Bacto tryptic soy broth and 1.5% w/v Bacto 
agar in 400 ml of deionized water). Autoclave the mixture and transfer 12 
ml aliquots of the resultant solution into sterile petri dishes. Solidified tryptic 
soy agar (TSA) plates can be stored at 4 °C for up to a month. 
10. 100ml of soft agar (1% w/v peptone and 0.5% w/v Bacto agar in 100 ml 
deionized water). Autoclave the mixture and cool to 45 °C in a water bath 
for immediate use. Otherwise, the solution can be stored at room 
temperature for up to a month.   
11. Ice bath 
12. Fresh plate of P. aeruginosa clinical isolate In7 which produces 3OC12HSL  
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13. Fresh plate of engineered E. coli with Sense-Kill-Release functions (QS-
S5-E7, Ampr) 
14. Control plate of engineered E. coli with only Sense-Kill functions (QS-S5, 
Ampr) 
 
8.1.7 Live and Dead Fluorescent Microscopy 
1. Incubator with shaking function 
2. Round bottom cell culture tubes with caps 
3. Membrane filters 0.2 µm  
4. Syringes 5ml 
5. Bacterial viability kit (Invitrogen) 
6. Fluorescent microscope with high resolution camera (Zeiss Axio Scope 
A1). 
 
8.1.8 Co-culture Inhibition Assay of Engineered E. coli and P. 
aeruginosa 
1. Microplate reader with programmable time-based fluorescence functions. 
(Biotek, Synergy HT Multi-Mode Microplate Reader recommended) 
2. MS Excel (Microsoft Office 2010 or equivalent) 
3. 96-well microplate (Greiner 96-well CellStar®, black) 
4. Round bottom cell culture tubes with caps 
5. 10 ml of LB broth with ampicillin (100µg/ml). 
6. Optional. LB agar plate with chloramphenicol (100µg/ml) 
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7. Fresh plate of P. aeruginosa clinical isolate In7 carrying plasmid pMC-
PAGFP/CM (see Note 1)  
8. Fresh plate of engineered E. coli with Sense-Kill-Release functions (QS-
S5-E7, Ampr) 
 
8.1.9 Biofilm Inhibition Assay 
1. Incubator with shaking functions 
2. 12-well microplate (Nunc, clear) 
3. Microplate sealing films 
4. Thin glass coupons 
5. MHB with chloramphenicol  
6. MHB with ampicillin 
7. LB agar plates with chloramphenicol (50µg/ml) 
8. Fresh plates of P. aeruginosa clinical isolate In7 and PAO1 carrying 
plasmid pMC-PAGFP/CM. PAO1 is used as a negative control in this 
experiment as it has resistant to pyocin S5 
9. Fresh plates of engineered E. coli with full Sense-Kill-Release functions 
(QS-S5-E7, Ampr) 
10. Fresh plates of engineered E. coli with partial Sense-Kill or Sense-Release 
functions. (QS-S5 or QS-E7, Ampr) 
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8.2 Recipes – Engineering Digital Logic Operations in Microbe 
8.2.1 BioBrick Assembly 
1. Thermocycler 
2. DNA Nanodrop 
3. Microcentrifuge 
4. Heat block 
5. Amplified PCR insert  
6. Biobrick vectors pSB4A5 (AmpR) or pSB1C3 (CmR) 
7. Restriction enzymes EcoRI-HF, XbaI, SpeI, PstI (New England Biolabs) 
8. rAPid alkaline phosphatase (Roche) 
9. T4 DNA ligase  
10. Minelute gel purification kit (Qiagen) 
11. PCR purification kit (Qiagen) 
 
8.2.2 Characterisation and Orthogonal Testing of Input Switches  
1. Microplate reader with fluorescence and absorbance measurement 
functions. (BMG Lab Technologies) 
2. Matlab with Curve Fitting Toolbox (The Mathswork, Natwick) 
3. MS Excel (Microsoft Office 2010 or equivalent) 
4. Microplate incubator with heated lid (Biofrontier) 
5. Multi-channel pipette 
6. 100× arabinose and rhamnose (2.8 M).  
7. Fresh plate of E. coli that expresses RFP when induced with input inducer 
(pBAD-RFP and pRHAB-RFP, Ampr) 
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8. Fresh plate of E. coli with orthogonal testing construct (pRHAB-RFP-pBAD-
GFP, AmpR) 
 
8.2.3 Characterisation of AND, OR, IMPLY Gates 
1. Microplate reader with fluorescence and absorbance measurement 
functions. (BMG Lab Technologies) 
2. Matlab with Curve Fitting Toolbox (The Mathswork, Natwick) 
3. MS Excel (Microsoft Office 2010 or equivalent) 
4. Microplate incubator with heated lid (Biofrontier) 
5. 96-well microplate  
6. Multi-channel pipette 
7. 100× arabinose and rhamnose (2.8 M).  
8. Fresh plates of E. coli with AND (pSB4A5, AmpR) and OR (pSB1A2, AmpR)  
constructs 
 
8.2.4 Parts Mutagenesis of λCl Repressor Binding Sites 
1. Thermocycler 
2. Gel electrophoresis setup  
3. Phusion DNA polymerase 
4. Forward primer 5’-TTCGAATTCGCGGCCGCTTCTAGAGGCCGGATTAT  
5. Reverse primer 5’-
CTACTAGTATATNNNNNNNNCCGGTGATATATGGAGAAACAGTA  
6. Microplate incubator with heated lid (Biofrontier) 
7. LB agar plate with chloramphenicol  
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8. 96-well microplate  
9. Microplate reader with fluorescence and absorbance functions (BMG Lab 
Technologies) 
10. Autoclaved toothpicks 
11. 100× Arabinose stock (0.35 M)  
12. 100× Rhamnose stock (2.8 M)  
13. Plasmid template pBADCl2A-RFP  (pSB1C3, CmR) 
14. Plasmid pHrpL-λCl (pSB1C3, CmR) 
15. Competent cells with pBAD-HrpS-pRHAB-HrpR (pSB4A5, AmpR) 
 
8.2.5 Characterisation of XOR Gate, Half Adder and Half Subtractor 
1. Microplate reader with monochromatic fluorescence and absorbance 
measurement functions. (Synergy H1m, Biotek Instruments) 
2. Matlab with Curve Fitting Toolbox (The Mathswork, Natwick) 
3. MS Excel (Microsoft Office 2010 or equivalent) 
4. Thermomixer (Eppendorf) 
5. 1.5ml microcentrifuge tubes  
6. 100× arabinose and rhamnose (2.8 M).  
7. Fresh plates of E. coli with AND (pSB4A5, AmpR) and OR (pSB1A2, AmpR)  
constructs 
 
8.2.6 Flow Cytometry of Half Adder and Half Subtractor 
1. Thermomixer (Eppendorf) 
2. LSR Fortessa X-20 with 488nm excitation laser (BD Bioscience) 
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3. FlowJo (TreeStar) 
4. 1.5ml microcentrifuge tubes 
5. Flow cytometry tubes (BD Bioscience) 
6. 100× Arabinose stock (0.35 M)  
7. 100× Rhamnose stock (2.8 M)  
8. Fresh plates of E. coli with half adder and half subtractor constructs 
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